Profiling Enterovirus and Parvovirus B19 in sudden and unexpected death in infancy (SUDI) at the Tygerberg Medico-legal Mortuary and the role of myocarditis as a possible cause of death by Saayman, Jamie Ester
Profiling Enterovirus and Parvovirus B19 in sudden and 
unexpected death in infancy (SUDI) at the Tygerberg Medico-
legal Mortuary and the role of myocarditis as a possible cause 
of death 
by 
Jamie Saayman 
Thesis presented in fulfilment of the requirements for the degree of Master of Science 
in the Faculty of Medicine and Health Science at Stellenbosch University 
Supervisor: Dr Corena de Beer 
Co-supervisor: Prof. Johan Dempers 
March 2018
ii 
DECLARATION 
By submitting this thesis, I declare that the entirety of the work contained herein is my own, original work and 
that I have not previously in its entirety or in part submitted it for obtaining any qualification elsewhere. 
_________________________ _________________________ 
Signature Date 
Copyright © 2018 Stellenbosch University 
All Rights Reserved 
Stellenbosch University  https://scholar.sun.ac.za
iii 
ABSTRACT 
Background: Sudden infant death syndrome (SIDS) remains one of the leading causes of death among 
infants. The Triple-Risk Model has contributed to identifying modifiable risk factors that may lead to a 
reduction of SIDS occurrences. Cardiovascular infection contributes significantly to mortality and 
morbidity in children and adults. Acute myocarditis affects infants more severely than adults and has a 
known association with Coxsackie-B, Adeno-, parvo- B19, Epstein Barr-, Cytomegalo-, Human herpes-
6 viruses. These viruses have been explored in sudden unexpected death in infancy (SUDI) and shown 
some association between SIDS and myocardial infection. 
Aim: This study aimed to describe two cardiovascular viruses in SUDI cases and to determine the 
association of myocarditis to these deaths. 
Methodology: Heart swab and tissue samples were prospectively collected from SUDI cases at the 
Tygerberg Medico-legal Mortuary over a one year period. The samples were collected in parallel with 
routine heart swabs for microbiology analysis and peripheral blood for HIV screening. The SUDI samples 
were additionally screened for enterovirus and parvovirus B19 by polymerase chain reaction assays. The 
heart tissue was processed for histological analysis. Sociodemographic information, medical history and 
final cause of death were obtained during the initial interview with family / caregiver(s) and from case 
files respectively, and potential risk factors in the SUDI population were identified from the data by 
statistical analysis. 
Results: Heart swab and tissue samples were collected from 168 and 161 SUDI cases respectively. The 
SUDI population consisted of 81 males and 87 females. Majority of deaths (64%) were in infants younger 
than 14 weeks and 67% occurred during the colder months of the year. In more than half of the cases an 
infectious cause of death was confirmed, while in 40% death was attributed to SIDS. There was a higher 
frequency of death among black infants, which is consistent with the literature, however it is not clinically 
relevant as it is not a representation of the general population profile in the Western Cape. The heart tissue 
for histology was within normal limits in all but 10 of 161 SUDI cases examined for morphological change 
associated with viral myocarditis, and 1 of these 10 cases was diagnosed as myocarditis as the final cause 
of death. The only significant risk factor identified in this population was ethnicity, but the finding was 
not clinically relevant. 
Conclusion: The results obtained from this study support the Triple-Risk Model of SIDS. The high 
proportion of deaths that remained unexplained (i.e. SIDS) emphasizes the need to introduce additiona l 
testing, such as molecular based tests which provide significant value when establishing a final cause of 
death. SIDS research in South Africa is limited and would be valuable in the forensic environment. 
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OPSOMMING 
Agtergrond: Skielike sterfte in babas (SIDS, SUDI of “wiegiedood”) is steeds een van die hoofoorsake 
van dood by babas. Die Triple-Risk Model het bygedra tot die identifisering van sekere risikofaktore wat 
kan lei tot 'n vermindering in wiegiedood gevalle. Kardiovaskulêre infeksie dra aansienlik by tot 
mortaliteit en morbiditeit in kinders en volwassenes. Akute miokarditis affekteer babas meer ernstig as 
volwassenes en het 'n bekende assosiasie met Coxsackie-B, Adeno-, parvo-B19, Epstein Barr-, 
Cytomegalo-, Human herpes-6 virusse. Hierdie virusse is ondersoek in skielike sterftes in babas en het 'n 
assosiasie tussen wiegiedood en miokardiale infeksie getoon. 
Doel: Hierdie studie het twee kardiovaskulêre virusse in SUDI-gevalle ondersoek en die bydrae van 
miokarditis tot hierdie sterftes geëvalueer. 
Metodes: Deppers en weefsel van die hart is prospektief versamel van SUDI-gevalle by die Tygerberg 
Mediesgeregtelike Lykshuis oor 'n een jaar tydperk. Hierdie monsters is versamel bo en behalwe die 
roetine hart deppers vir mikrobiologiese kweking en perifere bloed vir MIV-sifting. Die SUDI monsters 
is addisioneel getoets vir enterovirus en parvovirus B19 deur middel van ŉ polimerase kettingreaksie 
metode. Die hartweefsel is geprosesseer vir histologiese analise. Sosiodemografiese inligting, mediese 
geskiedenis en finale oorsaak van dood is verkry tydens die oorspronklike onderhoud met familie / 
versorger(s) en gevalle lêers onderskeidelik, en potensiële risikofaktore in die SUDI studiegroep is met 
statistiese analise geïdentifiseer. 
Resultate: Deppers en weefsel van die hart is onderskeidelik van 168 en 161 SUDI gevalle versamel. Die 
studiegroep het 81 seuntjies en 87 dogtertjies ingesluit. Die meerderheid sterftes (64%) het voorgekom in 
babas jonger as 14 weke en 67% van die gevalle het gedurende die kouer maande van die jaar voorgekom. 
In meer as die helfte van die gevalle is 'n infektiewe oorsaak van dood bevestig, terwyl die oorsaak van 
dood in 40% aan SIDS toegeskryf is. Daar was meer swart babas wat gesterf het en hoewel hierdie neiging 
ooreenstem met die literatuur, is dit nie verteenwoordigend van die algemene bevolking in die Wes-Kaap 
nie en dus nie klinies relevant nie. Morfologiese veranderinge in die hartweefsel van die gevalle was binne 
normale perke in 151 van 161 gevalle. In die 10 gevalle met abnormale histologie, het die veranderinge 
gedui op virale miokarditis, maar die finale oorsaak van dood is in slegs 1 geval as miokardit is 
gediagnoseer. 
Gevolgtrekking: Die bevindings van die studie ondersteun die Triple-Risk Model van SIDS. Die hoë 
persentasie onverklaarbare sterftes (d.w.s. SIDS) beklemtoon die noodsaaklikheid om addisione le 
analises, soos molekulêre toetse in te sluit in die bepaling van die oorsaak van dood om meer lig te werp 
op die tipe sterftes. Sulke navorsing in Suid Afrika is uiters beperk en sal ŉ waardevolle bydrae kan lewer 
in die forensiese veld.  
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CHAPTER ONE  
INTRODUCTION 
Sudden infant death syndrome (SIDS) is a devastating event that may torment affected families for a 
long time. SIDS is a common cause of death in infants previously thought to be healthy (Byard & 
Marshall 2007). SIDS is defined as the sudden and unexpected death of an infant during their first 
year of life which remains unexplained even following the conduction of a thorough post-mortem 
(PM) investigation, death scene and review of the clinical history (Beckwith 2003). Sudden 
unexpected death in infancy (SUDI) is a broader term used to define the death of infants younger than 
one year old that show no prior history of fatal illness or injury and is used to classify all cases of 
sudden infant death, whether explained, unexplained or unascertained. SIDS is one of the branches 
of SUDI (Weber et al. 2008a).  
In South Africa, children under one have the highest mortality rate within the pediatric range 
(Statistics South Africa 2015), and SIDS accounts for 3.41/1 000 live births in Cape Town – one of 
the highest rates in the world (Kinney & Thach 2009).  
Three factors have been highlighted in the literature that jointly trigger SIDS: a critical developmenta l 
period, a vulnerable infant, and exogenous stressors (Filiano & Kinney 1994). This has led to the 
identification of various risk factors commonly observed in SIDS cases, including a male 
predominance, peak during colder months, ethnicity, poverty, low birth weight and infection to name 
a few (Byard & Krous 2003). 
Infection is believed to be an important contributor to SIDS. Both viral and bacterial pathogens have 
been associated with SIDS, either as mediators of abnormal systemic immune response or as external 
stressors. Multiple pathogens have been identified in SUDI cases, although no single infectious agent 
has been consistently found to cause SIDS (Alfelali & Khandaker 2014; Weber et al. 2008a). 
Cardiovascular infection in SIDS remains controversial. However, there is an increase in the number 
of reports of heart disease, especially myocarditis, in SUDI (Dancea et al. 2002). Although clinica l 
myocarditis is rare in infants, asymptomatic cases are more common and have been reported in SIDS. 
Weber et al. (2008b) and Dettmeyer et al. (2004) have shown the prevalence of myocarditis in SIDS, 
and identified coxsackievirus B (CVB), human adenovirus (HAdV), parvovirus B19 (B19) and 
human herpesvirus (HHV) 6 and Epstein-barr virus (EBV). 
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PM investigations are extremely important in SUDI cases, especially to ascertain an exact cause of 
death and/or rule out SIDS in these cases. What is alarming is that the great majority of SUDI cases 
are ultimately classified as SIDS (Weber et al. 2008a). In South Africa, according to the South African 
Inquests Act (Act 58 of 1959), deaths considered to be from other than natural causes are investiga ted 
by the South African Police Service and referred to a medical practitioner who may, if necessary, 
perform an autopsy to ascertain the cause of death; these include SUDI cases. For diagnosis of SUDI 
cases, a proper protocol needs to be followed. However, no nationally accepted guideline for sudden 
infant death exists in South Africa; and therefore, different guidelines for such cases are followed by 
different institutions in South Africa and around the world (Livesey 2005; Bajanowski et al. 2007; 
du Toit-Prinsloo et al. 2011; du Toit-Prinsloo et al. 2013). At Tygerberg Medico-legal Mortuary all 
cases are investigated as per the standard facility protocol, which may include a death scene 
investigation (DSI) and medical history review, autopsy and limited laboratory investigations. All 
SUDI cases are also subjected to viral culture screening, specifically for HAdV, Cytomegalovirus 
(CMV), Influenza virus A and B, human parainfluenza virus 1, 2 and 3 and respiratory syncytial virus 
(RSV) from lung and liver tissue (la Grange et al. 2014). 
Apart from South Africa, limited research is conducted in Africa regarding SIDS (Ibeziako et al. 
2009), and no research has thus far investigated cardiovascular pathogens in SUDI cases. This 
introduces a special field of interest in SIDS by researchers in Africa.  
Therefore, the aim of this project was to investigate two cardiovascular pathogens in SUDI cases and 
to assess whether the pathogens play a significant role in the final cause of death (COD). 
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CHAPTER TWO  
LITERATURE REVIEW 
2.1 A historical background of sudden infant death 
Sudden death in infants is not a new disease but has been around for many years and was first 
described in the Bible where an infant had died as a result of an accidental suffocation event (Byard 
& Krous 2003). SIDS was first described in 1969 as “The sudden death of any infant or young child, 
which is unexpected by history, and in which a thorough post-mortem examination fails to 
demonstrate an adequate cause for death”. However, due to the ambiguity in the 1969 definition, it 
was amended in 1989 to “The sudden death of an infant under one year of age, which remains 
unexplained after a thorough case investigation, including performance of a complete autopsy, 
examination of the death scene, and review of the clinical history” (Beckwith 2003).  
2.2 The evolution of sudden infant death 
SIDS is a branch of SUDI, sometimes referred to as sudden unexpected infant death (SUID). SUDI, 
used as a more circumstantial term for any sudden and unexpected death in an infant (Berkowitz 
2012), defines the sudden and unexpected death of any infant, generally while asleep, that is between 
7 days and 1 year old, showing no history of fatal injury or illness (Weber et al. 2008a). SUDI is used 
as a multifarious term for the diagnosis of all cases of sudden death in infants. Three categories of 
SUDI have previously been described, namely explained death, unascertained death and unexpla ined 
death. These classifications are established after a thorough PM investigation has been conducted, 
which includes reviewing of the death scene and clinical background. Death as a result of a known 
COD, such as infection, infanticide, cardiac defects, and previously undiagnosed metabolic disorders, 
is known as explained SUDI, while death where the COD is perhaps difficult to establish due to 
inadequate information, such as in a case of possible accidental suffocation, bed sharing or asphyxia, 
is known as unascertained SUDI. When the COD remains unexplained after all the investigat ion 
procedures have been followed, it is classified as SIDS (Krous 2010; Schnitzer et al. 2012; Kennedy 
2016).  
SIDS is known as a complex disease of which the exact cause is still unclear. The major theory 
associated with the events leading to SIDS has been defined as the Triple-Risk Model (Filiano & 
Kinney, 1994). Spinelli et al. (2017) summarized the emergence of the multifaceted hypothesis first 
theorized by Wedgwood (1972) as the Multiple Contingency Theory, and just over a decade later 
formulated by Filiano and Kinney as the Triple-Risk Model (Figure 2.1). The development of this 
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theory has led to the notion that SIDS may result when there is an overlap of three main factors, 
namely: a) an infant that is innately weak, b) experienced a critical development phase in homeostatic 
control and c) exposed to some sort of external stressor. The susceptibility of an infant may not 
manifest until the infant crosses into the critical developmental phase and is subject to an external 
stress (Filiano & Kinney 1994). The Triple-Risk Model does not provide information on the mode or 
mechanism of death leading to SIDS, however it has assisted in identifying some of the risk factors 
associated with SIDS cases. 
 
Figure 2.1. Triple-Risk Model (adapted from Filiano & Kinney 1994). 
2.3 Incidence and risk factors in SUDI and SIDS 
Infant mortality in South Africa is a major problem, particularly due to the high rates which are 
increased by the burden of human immunodeficiency virus (HIV)/AIDS (Sartorius et al. 2011). 
Incidence rates for SIDS in South Africa are poorly reported, with greater emphasis placed on the 
rates of overall infant death. A national report on the mortality and causes of death in South Africa in 
2014 (Statistics South Africa, 2015) indicated that infant mortality (<1 year old) remains highest in 
the pediatric population (1 to 14 years, as classified by the Department of Health in 2012). In terms 
of geographic location, most infant deaths occurred in North-West province. Respiratory and 
cardiovascular disorders specific to the perinatal period (20th week of pregnancy to 7 days after birth, 
as classified by the Department of Health 2012) were the leading causes of death in infants within the 
neonatal period (birth to 28 days, as classified by the Department of Health 2012), followed by 
intestinal infection and respiratory (influenza and pneumonia) infections within the postneonatal 
period (between 4 weeks and 1 year old, including neonatal period). Malnutrition and other acute 
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respiratory infections were among the top ten leading causes of death among infants (Age Definit ions 
2012; Statistics South Africa, 2015).  
SIDS is a crucial topic of interest and poses a great threat to infants worldwide, specifically because 
no single cause has been identified yet that may aid in preventing these deaths from occurring. 
Globally, SIDS was attributed to approximately 15 000 infant deaths in 2013 (Vos et al. 2015), and 
persists as a leading cause of death in the postneonatal period after congenital malformation, 
conditions related to low birth weight and maternal complications in the United States of America 
(USA) (Matthews et al. 2015). Trends in SIDS rates were shown to be highest in New Zealand with 
a rate of 0.80/1 000 live infants, followed by the USA and United Kingdom (UK) with 0.57/1 000 
and 0.41/1 000 respectively, and Japan and The Netherlands with 0.09/1 000 and 0.01/1 000 
respectively (Kinney & Thach 2009).  
Since the recognition of the Triple-risk Model, identifiable risk factors (Figure 2.2) have been 
discussed in the literature that have contributed to a better understanding of SIDS. These risk factors 
all form part of Triple Risk Model. 
 
Figure 2.2. Some of the common risk factors of SIDS (adapted from Byard & Krous 2003). 
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Infant vulnerability may be attributed to prematurity, low birth weight, self-reported pre- or postnatal 
exposure to parental tobacco, pre-existing metabolic disorders or common mutations that increase 
susceptibility to specific environmental factors and infection (Fleming et al. 2015). Cigarette smoke 
in particular is extremely detrimental to the developing infant (i.e. prenatal exposure); and affects 
development and maturation of the infant’s autonomic nervous system as well as respiratory function 
(Blood-Siegfried 2009). A recent study showed a strong association between brainstem abnormalit ies 
and SIDS, where abnormally high total serotonin neurons were observed in SIDS cases compared to 
non-SIDS control cases (Bright et al. 2017). Alcohol exposure during pregnancy is especially 
dangerous as it can pass freely across the placenta and will remain in the fetal system longer than in 
the maternal circulation, increasing the risk to the infant. The Western Cape has one of the highest 
incidences of Fetal Alcohol Spectrum Disorders in South Africa and previous studies have shown 
that a high percentage of women admitting to regularly consume alcohol during pregnancy (May et 
al. 2014).  
Males have a greater risk to SIDS than females, with an incidence rate of 2:1 (Kinney & Thach 2009). 
Elhaik (2016) proposed the allostasis model to explain the major risk factors of SIDS being associated 
with brain function. Increased in utero exposure to different stressors, pain and trauma induces 
allostatic overload, i.e. a maladaptive effect in the developing nervous system that may affect later 
adaptability to environmental or iatrogenic stress. He postulated that neonatal male circumcision may 
increase allostasis, as the surgical procedure constitute intra- and postoperative risks, such as intense 
pain, cardiorespiratory shock and infection, among others. This can lead to increased vulnerability of 
male infants, also predisposing them to an increased risk for SIDS, however this theory is still to be 
proven. 
The first six months of life may be regarded as a critical developmental period during which the infant 
immune system is still developing, and SIDS is common during this period with a peak incidence 
between two and four months old (Kinney & Thach 2009, Blackwell et al. 2015). 
External factors such as maternal parity, low socioeconomic background, mothers with low 
educational background; as well as young mothers, particularly those younger than 20 years old are 
also associated with increased risk to SIDS (Byard & Krous 2003; Mitchell & Krous 2015; Ndu 
2016). Furthermore, seasonality also plays an important role as an external risk factor. SIDS rates are 
higher during the colder months during which infants are highly susceptible to infection, particular ly 
respiratory infection (Kinney & Thach 2009). Major differences in SIDS incidence are also observed 
in social and racial groups, specifically within the different ethnic groups (Matthews et al. 2015). 
SIDS rates in the USA (Hunt & Hauck 2006) and New Zealand are higher in black infants than in 
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white infants, which has been associated with such socially- and culturally-related risk factors as 
listed above (Mitchell et al. 1993; Blair et al. 2006). 
Sleep-related risk factors include prone sleeping, bed sharing and excessive bedding/clothing 
(including soft bedding or objects). These factors can either play an independent role in the 
pathogenesis of SIDS, or can function as a combination of one or more factors potentiating asphyxia 
(Hunt et al. 2015). Bed sharing specifically is common practice within some ethnic groups and 
individuals characterized by poor maternal education, socioeconomic deprivation, as well as 
premature or very young and vulnerable infants (Colson et al. 2013).  
From the first appearance of SIDS in the Bible, and in its definition, sleep-related suffocation or 
accidental death has been a major contributing factor for SIDS. This dates as far back to the 1940s 
when Abramson (1944) showed an extreme incidence of infant death due to accidental mechanica l 
smothering, which was the highest mortality rate due to accidental death in infants in New York City 
at the time of the study. The mechanisms by which accidental suffocation may occur are described in 
Table 2.1. The way in which an infant is put to bed plays an important role as a risk factor for SIDS. 
An infant placed to sleep in the prone (faced-down) position will be at a higher risk for suffocat ion 
or smothering than when placed on the side or back (supine). Although the supine sleeping position 
is regarded as the safest, many infants are placed on their side. This position can also be risky at times, 
as an infant is more likely to roll over to the prone than supine position when placed on their side 
(Katwinkel et al. 2000). Previous studies have highlighted the risk of SIDS in infants that are placed 
to sleep in the prone position (Abramson 1944; Ponsonby et al. 1993; Dwyer & Ponsonby 1996; 
Schnitzer et al. 2012). Since prone sleeping was identified as one of the leading risk factors associated 
with SIDS, New Zealand first initiated the implementation of back-to-sleep campaigns during the 
1980s where awareness was raised about the risk of placing infants on their stomach and 
recommendations were made to place infants on their backs or side to sleep. Such campaigns have 
subsequently also shown great success in countries such as the USA and UK (Katwinkel et al. 2000; 
Gilbert et al. 2005). During the 1980s and 1990s, significant decreases of 50-90% in SIDS incidences 
were observed, where much of this decline was attributed to the use of the supine sleeping position 
(Moon et al. 2007). 
Although prone sleeping is known to increase the risk of asphyxia in infants, it may also increase 
their susceptibility to infection (Blackwell et al. 1999). Respiratory symptoms are often observed in 
SIDS cases prior to death, suggesting some type of infection. Toxigenic bacteria have been isolated 
from the gastrointestinal tract in SIDS cases and infants who slept in the prone position have been 
Stellenbosch University  https://scholar.sun.ac.za
8 
associated with increased colonization of Escherichia coli (E. coli) and Staphylococcus aureus (S. 
aureus) isolated from the nasopharyngeal ducts (Goldwater 2004). 
Table 2.1. Mechanisms for accidental suffocation (adapted from Abramson 1944 and Shapiro-Mendoza et al. 
2014). 
Mechanism Definition 
Overlay When sharing a bed or sleep surface with an infant and the person rolls over or against 
the infant, blocking the airway or compressing the neck/chest region of the infant 
causing the infant to stop breathing 
Soft bedding Soft blankets, duvets, pillows, mattresses, stuffed toys, etc. on the bed that may block 
the airway of the infant causing the infant to stop breathing 
Wedging or 
entrapment 
When an infant is entrapped between two objects, e.g. mattress and wall, or even 
against the mother’s breasts or upper limb that may block the airway of the infant 
causing the infant to stop breathing 
Other Any other sleep-related factor that may block the airway of the infant causing the 
infant to stop breathing. 
The role of infection in the pathogenesis of SIDS remains a crucial topic of interest in the field as a 
variety of pathogens are constantly found in these cases. Histopathological features, specifically in 
the upper respiratory tract, often show mild inflammatory changes in SUDI cases and may suggest 
an active infection at the time of or immediately prior to death (Weber et al. 2010a). Several studies 
have investigated the association of viral and bacterial infections and toxins to SIDS. Burger et al. 
(2014) explored the presence of CMV, HAdV and RSV in the lungs of SUDI cases in South Africa. 
Parainfluenza virus type 2 was detected in bone marrow and liver tissue in a case of sudden infant 
death in Japan (Kashiwagi et al. 2004). S. aureus and S. enterotoxins (Harrison et al. 1999; Highet et 
al. 2009), Streptococcus agalactiae (Highet et al. 2014), E. coli (Pearce et al. 2010), and Bordetella 
pertussis (Heininger et al. 2004) have all previously been detected in SIDS cases.  
2.4 Viral infection in SUDI 
The role of viral infections in SIDS is not yet fully understood. Viruses are thought to cause either 
straightforward infection which elicits a cytokine response, or can work synergistically with bacteria 
by attracting pathogenic bacteria to colonize the region and cause infection when toxins are produced. 
The presence of respiratory pathogens have most commonly been associated with either an infect ion, 
or just being present in infants during the postneonatal period, and not necessarily resulting in 
infection. Acute infections related to respiratory viruses are the major cause of death globally in 
children younger than 5 years. Mild respiratory infections are also common in about 80% of SIDS 
cases (Cutz and Jackson 2001), and present as flu-like symptoms prior to demise. Although frequently 
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isolated, no specific respiratory or any other virus has been found to have a self-sufficient lethal effect 
in SIDS (Bajanowski et al. 2003; Highet 2008).  
Cardiovascular viruses in SUDI  
Evidence on the role of viruses in heart disease has been well documented between the 18 th and 19th 
century. Cardiopathies associated with viral infection are frequently related to enteroviruses (EV), 
especially in the case of myocarditis. Such cardiopathies may be caused by direct infection with the 
virus or by maternal transmission during pregnancy. Coxsackieviruses also have a known role in the 
etiology of cardiovascular infection (Kawana 1985). Myocarditis affects the heart muscle as a result 
of inflammation, either focal or diffuse, and with or without myocytolysis, which is normally 
triggered by an infectious agent – although it may be accompanied by autoimmune disease, 
hypersensitive reactions and toxins. It has been associated with the parasite, Trypanosoma cruzi, but 
in children it is more commonly associated with viruses. EV, specifically CVB, is the most common 
cause of pediatric myocarditis. With the use of molecular-based techniques such as polymerase chain 
reaction (PCR), other viruses including HAdV, B19, CMV, HHV6 and EBV have now also been 
identified and implicated in myocarditis (Uhl 2008; Canter & Simpson 2014) (Figure 2.3).  
 
Figure 2.3. Viruses implicated in myocarditis (adapted from Shauer et al. 2013). 
Myocarditis has been recognized as a cause of sudden and unexpected death in both children and 
adults. It is often characterized as a subclinical disease; however it may lead to fatal heart failure and 
even sudden cardiac death. Acute myocarditis is one of the challenging diseases to diagnose, as the 
clinical presentation is often variable and non-specific. Presentation of the disease varies between 
asymptomatic and mild to severe illness and acute or cardiac arrest, and symptoms, if clinica lly 
identified, may include mild fever, and respiratory- or gastrointestinal-associated infection (Shauer 
et al. 2013). Diagnosis of the disease remains controversial due to the inconsistency in the methods 
of detection. Diagnosis of myocarditis relies primarily on histological (histopathological or 
immunohistochemical) analysis of the myocardial tissue (usually an endomyocardial biopsy), 
although other diagnostic methods, such as PCR and in-situ hybridization, are more frequently being 
used for viral detection (Mahfoud et al. 2011). Histologic examination, the cornerstone for diagnos is 
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of acute myocarditis, generally follows the Dallas criteria, i.e. the presence of inflammatory infiltra tes 
with or without myocytic necrosis. Discrepancies exist with regards to tissue sampling and the way 
in which medical professionals interpret histologic results, questioning its sensitivity. Controversy 
regarding the reliability of the Dallas criteria for diagnosis of myocarditis has been discussed 
previously, which highlighted the fact that other methods should be included in diagnosis to affirm 
the COD as myocarditis (Baughman 2006). Variation in the clinical presentation and histologica l 
interpretation of myocarditis could explain why the exact frequency of myocarditis as a cause of 
paediatric sudden death is still uncertain and the natural history of acute myocarditis remain 
controversial (Dennert et al. 2008; Weber et al. 2008b). 
An association of sudden infant death and acute myocarditis has been shown in the literature. The 
number of reports of heart disease is significantly increasing in sudden and unexpected death in the 
infant population (Dancea et al. 2002), especially viral myocarditis (Weber et al. 2008a). Due to the 
sporadic occurrence of fatal myocarditis in SUDI, the true incidence remains unknown. One of the 
largest descriptive studies in the USA in children under 19 years old showed a significant incidence 
of acute myocarditis especially among infants (Figure 2.4). A prospective study in Germany 
investigating the presence of myocarditis-associated viruses (CVB, HAdV, EBV, B19, HHV6) in 
SIDS cases showed a high incidence of 43.5% for one of the viruses (Dettmeyer et al. 2004); 
compared to 16.8% shown in a previous study where myocardial involvement detected by histology 
was observed (Rambaud et al. 1992).  
EV belong to the Picornaviridae family and include polio- and non-polioviruses (CVB, echoviruses 
and EV), which are some of the largest ribonucleic acid (RNA) viruses in humans and animals. These 
single-stranded (ss) RNA viruses are responsible for high mortality in newborns, and are known to 
cause subclinical infection. They have been associated with sepsis, meningoencephalitis, hepatitis 
and myocarditis (Inwald et al. 2004; de Crom et al. 2016). The spread of non-polio EV occurs via 
transplacental and feco-oral routes and respiratory aerosols (Hawkes & Vaudry 2005). EV infect ion 
is more common during the first two weeks of life, with a minimal chance of full recovery in 
newborns, and in the majority of cases, maternal infection was present prior to or shortly after birth 
(Freund et al. 2010). Jenista et al. (1984) observed an increased frequency of neonatal EV infect ion 
during the late summer/early autumn (June to October in USA). Most infants in their study presented 
no symptoms of infection. They suggested that there may be an association between breast-feeding 
and protection from infection.  
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Figure 2.4. Incidence of acute myocarditis in a pediatric population in the USA - 2006 to 2011 (Ghelani et al. 
2012). 
B19 belongs to the Parvoviridae family and is spread via respiratory aerosols, blood, household 
contacts and nosocomially. Infection may be asymptomatic, mild or severe; in children, it is 
associated with fifth disease (or erythema infectiosum) marked by a rash on the cheeks. B19 may 
display clinical features relating to flu-like symptoms and later on during viremia may present with 
antiviral antibodies (immunoglobulin [Ig] M and IgG). B19 infection is ubiquitous in the human 
population and pregnant women are known to have increased susceptibility to B19 infection. In 
pregnant women infected with B19, the virus may be transmitted to the fetus via the placenta and 
infect the liver of the fetus. It is also involved in the production of erythrocytes during early stages in 
development and as such may cause acute anemia or myocarditis (Young & Brown 2004; Tschöpe et 
al. 2005). B19 viral deoxyribonucleic acid (DNA) found in heart tissue have been associated with 
viral myocarditis and inflammation in the tissue was also evident (Pankuweit et al. 2003). Although 
EV and HAdV have been commonly associated with myocarditis in the past, B19 is emerging in the 
field of viral myocarditis (Shauer et al. 2013). B19 infection, especially in the myocardium of infants, 
may cause fatal acute myocarditis. Co-infection of B19 with other cardiovascular viruses is common 
and co-infection with HHV6 has been reported to cause fatal myocarditis. Transactivation of HIV 
and CMV by HHV6 has been observed previously (Alfaro et al. 2016). 
HAdV is a well-known pathogen responsible for respiratory infections in the pediatric population. 
This double-stranded (ds) DNA virus may cause sporadic infection throughout the year, and HAdV 
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epidemics have been reported. Clinical symptoms of HAdV infection may include wheezing, fever 
and hypoxia (Calvo et al. 2015). Previous studies have reported incidence rates of HAdV infection in 
children of up to 18% (Carballal et al. 2002; Jin et al. 2013; Ferone et al. 2014). HAdV infection is 
often associated with pneumonia, especially in patients with immunosuppression (Chen et al. 2013) 
and viral myocarditis (Bowles et al. 2003). 
HHV belonging to the Herpesviridae family, are known for their ability to remain latent in the body, 
as well as to be reactivated in immunocompromised individuals (Deback et al. 2008). HHV, CMV, 
HHV6 and EBV have been associated with myocarditis and sudden death (Dettmeyer et al. 2008; 
Mahfoud et al. 2011), moreover human herpes simplex virus (HSV) and EBV are clinically known 
to be cardiopathogenic when present in heart tissue samples (Dettmeyer et al. 2009). EBV, HHV6 
and CMV have been studied in a group of SIDS cases and compared with a control group of natural 
deaths. Significantly higher prevalence of EBV and HHV6 were detected in SIDS cases than in the 
controls, suggesting a possible association of these viruses with SIDS. The prevalence rates of CMV 
in the SIDS and control cases were not very different in this study (Álvarez-Lafuente et al. 2008), 
however it has been reported to cause severe infection in infants. 
EBV, also known as HHV4, is a dsDNA virus that is ubiquitous in the human population and is 
known to cause asymptomatic infection. Primary infection is more common in children and 
transmission is via the oral route (Linde & Falk 2007; Griffiths 2009). Condon et al. (2014) evaluated 
the prevalence of EBV infection in children under 20 years old in USA. They observed a 
seroprevalence of 31% in children under 5 years old in their population. 
CMV, also known as HHV5, is an opportunistic virus that frequently causes asymptomatic infections, 
but may present with non-specific respiratory-related symptoms and lead to severe illness, such as 
interstitial pneumonia. CMV infection is not uncommon during the first year of life, and may be 
associated with poor living conditions. CMV infection may result in significant fatality in 
immunosuppressed individuals, especially vulnerable infants, such as those born prematurely or with 
other pre-existing infection (i.e. congenital). Thus, infants in the perinatal and neonatal period are at 
a higher risk of disease progression upon initial infection as maternal antibodies against CMV have 
a protective role against in utero transmission and the infant immune systems are still 
developing/immature. The virus can be transferred to infants by infected mothers during delivery (via 
vaginal secretion), breastfeeding or via aspiration of maternal blood (Gandhi & Khanna 2004). A 
prospective study by Yagmur et al. (2016) investigated the prevalence of CMV infections in SUDI 
cases over a two-year period. They found that CMV-DNA was frequent in salivary glands and other 
tissue using molecular-based and histological techniques. They also found other viruses, such as EV 
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and HAdV in some samples. Histopathological findings showed features of CMV pneumonia and 
sialadenitis.  
HHV6 is a dsDNA virus which is present in a significant proportion of the population. Transmiss ion 
of HHV6 may occur perinatally, even if exposure to the virus occurred earlier in life and reached 
latency; and via the oral route. The incidence of HHV6 ranges from 10-66% in infants. Patients with 
an immune vulnerability, such as HIV, are more likely to experience reactivation. Common 
symptoms of infection in infants are marked by fever, respiratory and gastrointestinal symptoms and 
seizures (Kasolo et al. 1997; Leach 2016). 
CVB3 (Jin et al. 1990; Dettmeyer et al. 2002), HAdV, B19, EBV and HHV are frequently confirmed 
in SIDS cases by molecular methods, such as PCR, in situ hybridization and serology (Towbin et al. 
1993; Martin et al. 1994). 
2.5 Viral and bacterial screening in SIDS 
A significant proportion of SUDI is attributed to infection. Of the remaining cases, more than 60% 
remains unexplained (SIDS) following PM investigation, highlighting the urgency of additiona l, 
more sensitive diagnostic testing especially when addressing the infectious contribution in SIDS 
(Weber et al. 2008a). Conventionally, virus culture was used for virus isolation, but present difficulty 
and has been shown to provide low sensitivity and specificity for viral detection (Dennert et al. 2008). 
The low success rate of virus isolation associated with PM samples may be related to the quantity of 
virus in the sample, the demanding conditions of viral culture, the integrity and/or viability of viral 
RNA (or DNA) (Bajanowski et al. 2003). Alternative methods of screening for infection is 
emphasized in SUDI cases, especially molecular-based methods. Infection in SUDI cases has 
previously been identified by use of histology in conjunction with microbiology (Arnestad et al. 2002; 
Weber et al. 2008a). Since discrepancies, such as contamination, may occur during the autopsy, it is 
imperative to perform histopathological analysis as microbiology or virological results can be 
misinterpreted. However, risk of contamination during PM sampling can be reduced by the use of 
good aseptic practices. Currently, SUDI investigation protocols recommend that routine virologica l 
and bacteriological (sometimes toxicology and genetic screening) testing be included in PM 
investigations. Although no standardized guidelines exist that detail the major SUDI-related viruses 
or screening methods to be used, recommendation to improve detection of common viruses 
encountered in SUDI cases have been discussed. Molecular techniques allow for more targeted 
screening that is more specific and sensitive; hence strengthening the precision of diagnos is 
associated with infection (Freymuth et al. 2006; Weber & Sebire 2010; Weber et al. 2010a). 
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2.6 PM investigation in SUDI cases 
The role of PM investigation is imperative to understand why the rates of SIDS still remain high in 
developing countries and to try to contribute towards reducing the mortality rates. This can be 
achieved by implementing strategies or lifestyle changes for risk-related infants or households. One 
of the biggest challenges currently is the lack of a systematic protocol for investigation of SUDI cases; 
no nationally or internationally accepted guidelines exist. Controversies and inconsistencies in 
investigation approaches have been discussed previously which have led to differential diagnosis in 
SUDI cases (du Toit-Prinsloo et al. 2013; Brooks & Gill 2015). 
Bajanowski and colleagues (2007) discussed some recommendations that can contribute towards the 
implementation of a standardized diagnostic protocol for SUDI investigations (Table 2.2). DSI, as 
stated in the 1989 definition of SIDS, is important. Generally, this is done by police officials and 
requires specific training for SUDI investigations. In reality, forensic specialists, trained for such 
investigations, rarely assist with DSI. Radiology and histological investigation should also be 
included - especially assessment of the brain, lungs and heart, although other main organs should also 
be assessed to identify possible signs of injury or morphological changes (e.g. skeletal abnormalit ies, 
old bruises, lethal lesions, inflammation, hemorrhage, edema, etc.) that may aid in establishing a 
COD. Additional tests should include metabolic or genetic testing, microbiology and virology testing 
and toxicology (Bajanowski et al. 2007). 
Table 2.2. Recommended investigation approach for SUDI cases (adapted from Koehler 2010). 
Assessment Description 
DSI Secure and photograph death scene, conduct witness interview/s, re-
enact scene, compile death scene report 
Pre-autopsy investigation Review medical history (infant and mother if possible), DSI, case 
information, first responder and police reports 
Autopsy: external examination Photograph infant, assess appearance of infant (including signs of 
trauma/injury) 
Autopsy: internal examination Removal and assessment of organs 
Collect specimens, such as blood, tissue, etc. for histology, 
microbiology, toxicology, virology etc. 
Additional (may not be available 
in all cases) 
Collect epidemiological information 
At the Tygerberg Medico-legal Mortuary (Cape Town) all cases are investigated according to the 
standard facility protocol, which may include a DSI, autopsy and selected laboratory investigations . 
Shell vial culture (SVC) screening, specifically for HAdV, CMV, Influenza virus A and B, human 
parainfluenza virus 1, 2 and 3 and RSV from lung and liver tissue, bacterial isolation from the lungs 
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and heart (pus swabs), HIV analysis on blood and chemical pathology (urea and creatinine [U&C]) 
testing on serum are routinely performed on all SUDI cases admitted to the institution (la Grange et 
al. 2014). 
2.7 Where are we now with SIDS in Southern Africa 
SIDS research used to be underinvestigated in Africa (Ndu 2016), however more research is emerging 
in South Africa, particularly at academic institutions. SIDS mortality in mixed-race infants in Cape 
Town is considered among the highest, with an incidence of 3.41/1 000 live births (Kibel et al. 2005; 
Kinney & Thach 2009), seven times higher than the national average in USA (Goldstein et al. 2016), 
and 1.06/1 000 live births in white infants in Cape Town (Kibel et al. 2005). This may be 
representative of the population demographics within the Western Cape. 
In South Africa, all deaths due to unnatural causes (sudden and unexpected or unexplained included) 
are investigated according to the Inquests Act (Act 58 of 1959), where the body is admitted to a 
medico-legal mortuary for investigation. The investigation procedure at various medico-lega l 
mortuaries in South Africa is similar to that outlined in section 2.6. This includes reviewing of the 
clinical history of the case admitted, DSI, macroscopic assessment, radiology, histology of organ 
blocks, toxicology, microbiology, virology and genetic tests. The macroscopic assessment is 
performed either by complete evisceration of the body with dissection of organ blocks for macro- and 
microscopic analysis, partial assessment with or without evisceration due to COD becoming apparent, 
or no autopsy due to history displaying known underlying condition.  
The prevalence of SUDI in South Africa was investigated at two medico-legal mortuaries, Pretoria 
and Tygerberg (Cape Town) between 2000 and 2004. Over the four-year period 813 infant cases were 
admitted to the two centres, of which 99 (Pretoria) and 413 (Tygerberg) were identified as SUDI. 
Similar trends in these deaths were observed in the two study populations, such as male 
predominance, peak age of 2 to 4 months, high frequency in black and coloured infants and a peak in 
colder months (June to August, with another peak in December). Differences in additional laboratory 
analyses (such as histology, bacteriology, virology and toxicology) requested at autopsy were 
identified between the two centres. No DSI was performed for any of the cases. A total of 171 cases 
(161 Tygerberg, 10 Pretoria) remained unexplained (SIDS) following PM investigation, 34 were 
unascertained, 158 died due to infection (pneumonia) and 129 due to other causes (du Toit-Prins loo 
et al. 2011). A study by Dempers et al. (2016) in the Eastern Metropole of Cape Town reported 
similar findings. 
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The burden of cardiovascular infection is perhaps underdetermined in the field of sudden infant death 
due to a paucity of research to investigate the exact prevalence of the condition. In terms of 
cardiovascular disease in children (described as ‘ill-defined cardiovascular disease’ in children under 
5 years old) (Nannan et al. 2012), determining the true incidence in South Africa seems to be 
challenging, perhaps due to the difficulty in diagnosis of such disease (Figure 2.5).  
As part of the current study, a retrospective analysis was carried out to investigate the mortality rates 
attributed to cardiovascular diseases (either myocarditis or cardiovascular-related causes such as 
congenital cardiac conditions) at Tygerberg Medico-legal Mortuary between 2006 and 2015 (Figure 
2.6). Only the diagnosis of the final COD was used for this analysis. The incidence seemed to be 
much lower than what the literature suggests. The reason for this is not currently known, however, 
this introduced the need for more research in this field especially in South Africa - where such 
controversy could be addressed. 
 
Figure 2.5. Ranking of mortality rates for children under 5 years of age in 2007 (Nannan et al. 2012). 
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Figure 2.6. Number of infant deaths over 10 years at Tygerberg medico-legal mortuary. 
2.8 Research aims and objectives 
▪ Aim I: To develop PCR-based screening assays for specific viruses often associated with 
myocarditis 
o Objective I: To generate plasmid DNA as positive controls from known virus samples 
by cloning a fragment of the viral DNA into a suitable vector 
o Objective II: To optimize PCR assays for virus detection with the positive controls 
generated 
▪ Aim II: To profile EV and B19 in SUDI cases using molecular techniques 
o Objective III: To screen for EV and B19 viruses in SUDI heart swab samples using 
the PCR assays developed and optimised as part of Aim I 
o To analyse heart tissue samples to determine whether infection could be implicated in 
the final COD 
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CHAPTER THREE  
METHODOLOGY 
3.1  Study design 
SUDI cases admitted to the Tygerberg Medico-legal Mortuary, Eastern Metropole of the Western 
Cape, were prospectively investigated from June 2016 to June 2017. Heart swab samples were 
collected for viral screening and heart tissue samples were collected for histological examination for 
each case, which supplemented the routine diagnostic tests conducted by the Division of Forensic 
Medicine. Samples were collected from infants who died suddenly and/or unexpectedly, aged 
between 7 days and 1 year old. The first week of life is generally regarded as the neonatal period 
where the immune system of the infant may still be adapting to the extrauterine life and death during 
this time may often be as a result of birth defects or respiratory distress). All samples were collected 
at the time of autopsy under the auspices of the Inquests Act (Act 58 of 1959). 
3.2  Ethical consideration for study 
The protocol for this project was reviewed and approved by the Health Research Ethics Committee 
(HREC) at Stellenbosch University, Tygerberg Campus (Ref. number N12/02/007) and a waiver of 
consent was granted. All SUDI cases are required by law to be investigated in order to find a COD 
and as long as our study objectives did not deviate from the objectives set in the Inquests Act (Act 58 
or 1959), i.e. finding a COD, we were not required to obtain informed consent from the parents when 
admitting their infant to the Tygerberg Medico-legal Mortuary. 
3.3  Sample acquisition and storage of known virus samples 
Quality control for molecular diagnostics (QCMD) samples, EVRNA16C1-03 and B19DNA16C1-02, 
were collected from the National Health Laboratory Service (NHLS) Virology laboratory (Tygerberg 
campus) for EV and B19 respectively. EV and B19 QCMD samples were stored at -20°C upon 
collection for later construction of positive controls for the viral screening assays. 
3.4  Nucleic acid extraction and quantitation of EV and B19 
Total nucleic acid (TNA) extractions were done for EV and B19 QCMD samples using the QIAmp ® 
cador® Pathogen Mini Kit (QIAGEN®, Cape Town) following the manufacturer's instructions. 
Nucleic acid extractions were done at room temperature in a laminar flow cabinet.  
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For lysis of cellular debris, 20 µl of proteinase K and 200 µl virus-containing samples were added to 
350 µl Buffer ACB, pulse vortexed and incubated at room temperature for 15 minutes. Lysates were 
applied to QIAmp Mini columns provided in the kit and centrifuged at 8 000 revolutions per minute 
(rpm) for 1 minute. The samples were washed twice with 600 µl Buffer AW1 and centrifuged at 8 000 
rpm for 1 minute. A final centrifugation step was included to remove traces of ethanol from the wash 
buffer. Elution of the DNA was done in a nuclease-free 1.5 ml microcentrifuge tube with 40 µl Buffer 
AVE and the DNA was stored at -80°C to ensure increased stability.  
The NanoDrop ND-1000 spectrophotometer was used for the determination of the quantity and purity 
of the TNA extracted. Briefly, the upper and lower surfaces of the microspectrophotometer sample 
retention system were cleaned using clean deionized water and wiping it down with paper towel. The 
software system was opened and the nucleic acid module was selected. The spectrophotometer was 
initialized by placing 1 µl clean water onto the lower optic surface, lowering the arm of the device 
and selecting “initialize”. The upper and lower optical surfaces were cleaned with paper towel and 
1 µl of AVE Buffer was placed on the lower optic surface to blank the system. Both optical surfaces 
were again cleaned with paper towel. Depending on whether DNA or RNA was being analysed, the 
option was selected on the software prior to starting the sample analysis. To quantify the sample, 1  µl 
of the sample (RNA/DNA) was placed onto the lower optical surface, the arm of the 
spectrophotometer was lowered and the selection to “measure” was made on the software. The 
readings were saved into a Microsoft® Excel® spreadsheet for analysis.  
3.5  Reverse transcription (RT) assay  
After the TNA was recovered from the EV QCMD sample, complementary DNA (cDNA) was 
generated using the Maxima Reverse Transcriptase kit (Thermo Scientific™, Randburg) following 
the manufacturer’s instructions. The RT protocol followed consisted of a two-step process, and was 
performed using random hexamers, instead of universal primers, as the random primers can bind to 
any RNA species in a sample i.e. no template specificity required. The reaction was performed in a 
final volume of 20 µl followed by the modified instructions below: 
First step: 
Nuclease-free water 6.5 µl 
Random Hexamers (Primer) 2 µl 
dNTP mix 1 µl 
RNA template 5 µl 
Total volume in tube  9.5 µl 
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Second step: 
5 X RT Buffer 4 µl 
RNase inhibitor 0.5 µl 
Maxima RT  1 µl 
Total volume 5.5 µl 
Thermal cycling parameters: 
Denaturation, first step reagents 65°C 5 minutes 
Annealing 4°C 1 minutes 
Addition of second step reagents 
cDNA synthesis 25°C 10 minutes 
50°C 30 minutes 
Enzyme inactivation 85°C 5 minutes 
Holding  4°C ∞ 
The RT products were stored at -20°C. 
3.6  Pre-cloning PCR assay 
Primers were selected from literature (Table 3.1) to establish a PCR protocol for this study. The 
primers were analysed using the online database BLAST (https://blast.ncbi.nlm.nih.gov/) to confirm 
the binding sites to our viruses of interest. Each primer sequence was entered into the query box on 
the webpage and the “go” button was selected. The output generated a list of various binding sites 
corresponding to the virus of interest.  
Table 3.1. Primer sequences used for the amplification of EV and B19. 
Virus Primer sequence (5’- 3’) Reference Expected 
product size (bp) 
EV (a/b) * 
 
EV (a/c) ** 
a - TCC GGC CCC TGA ATG 
b - ACA CGG ACA CCC AAA GT 
c - CAC CGG ATG GCC AAT CCA 
Martin et al. 1994 151* 
 
196** 
PVB19 * 
 
PVB19 ** 
AGC ATG TGG AGT GAG GGG GC 
AAA GCA TCA GGA GCT ATA CTT CC 
GCT AAC TCT GTA ACT TGT AC 
AAA TAT CTC GTC GGG GTT GAG 
Bültmann et al. 2003 290* 
 
173** 
* First reaction, pre-nested primers 
** Second reaction, nested/hemi-nested primers 
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The cDNA/DNA for EV and B19 QCMD samples were detected by individual pre-nested PCR assays 
using a chemically modified recombinant Taq DNA polymerase, Maxima Hot Start (HS) Taq DNA 
Polymerase (Thermo Scientific™, Randburg). Pre-nested PCR reactions were performed in a final 
volume of 25 µl following the instructions below:  
Maxima HS Buffer  2.5 µl 
Forward primer 2.5 µl 
Reverse primer 2.5 µl 
MgCl2 2.5 µl 
dNTP mix 0.5 µl 
Maxima HS Taq 0.1 µl 
cDNA template 5 µl 
Nuclease-free water 9.4 µl 
Total volume 25 µl 
The reactions were placed into the GeneAmp® PCR System 9700 following parameters below: 
Initial Denaturation 95°C 4 minutes 
Denaturation 
Annealing 
Extension 
95°C 
Variable (see Table 2) 
72°C 
30 seconds (40 cycles) 
Final extension 72°C 7 minutes (20 minutes for pre-
cloning PCR) 
Holding 4°C ∞ 
 
Table 3.2. Annealing temperatures of the primers used for the amplification of EV and B19. 
Primers Annealing temperature (Ta) 
EV* 
EV** 
54.7°C 
57.3°C 
PVB19* 
PVB19** 
51.4°C 
47.5°C 
* First reaction, pre-nested primers 
** Second reaction, nested primers 
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3.7  Gel electrophoresis 
The PCR products were separated using a 2% agarose gel electrophoresis protocol. The agarose was 
prepared in a microwave safe glass flask using 2 g agarose powder in 100 ml 1X SB Buffer (Appendix 
A). The flask was placed in the microwave for 2 minutes or until the gel was completely dissolved 
(clear) and left to cool for a few minutes. While the gel was left to cool, the combs were inserted onto 
the casting plate and the routes leading to the electrical wires were sealed with molten agarose. Once 
the gel was cooled, 7 µl Ez-Vision® Blue Light DNA Dye (Inqaba Biotec™, Pretoria) was added to  
the agarose and the gel was carefully poured into the casting plate and left to set. Once the gel was 
set, the combs were removed from the gel and 1X SB Buffer was poured onto the set gel until the 
entire gel was covered with Buffer. The samples were loaded onto the gel by mixing 5 µl of the PCR 
product with 1 µl 6X DNA Loading Dye Buffer Orange and Blue (Separations Simply Spectacular, 
Cape Town). The gel casting plate was connected to the electricity supply and run at 90V for 30 
minutes. Following gel electrophoresis, the gel was visualized on the Gel Doc system.   
3.8  Purification of PCR products  
The PCR products were purified using the MiniElute PCR Purification Kit (QIAGEN®, Cape Town) 
following the manufacturer’s instructions. Briefly, five volumes of Buffer PB was added to 1 volume 
of the PCR reaction, pulse vortexed, applied to MiniElute column provided and centrifuged at 13 000 
rpm for 1 minute. The sample was washed with 750 µl Buffer PE and centrifuged at 13 000 rpm for 
1 minute. An additional centrifugation step was included at maximum speed for 1 minute to remove 
residual ethanol from Buffer PE, and the purified PCR product was eluted into sterile 1.5 ml 
microcentrifuge tube with 10 µl Buffer EB. The DNA eluted was stored at -20°C for further analyses. 
3.9  Molecular cloning assay 
A 30 µl overnight ligation reaction was set up for the EV and B19 purified PCR products using an 
InsTAclone™ PCR Cloning Kit (Thermo Scientific™, Randburg) following the manufacturer’s 
instructions. Briefly, 3 µl Vector pTZ57R/T, 6 µl Ligation Buffer, 1 µl T4 DNA Ligase, 17 ng and 
50 ng respectively (Table 3.3) were added and brought to a final volume of 30 µl with nuclease-free 
water. The reactions were placed into the GeneAmp® PCR System 9700 for incubation as follows: 
Ligation  25°C 2 hours 
4°C 2 hours (8 cycles) 
Enzyme inactivation 75° C 5 minutes 
Hold 4°C ∞ 
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The ligation reactions were stored at -20°C for further processing.  
Lysogeny broth (LB) and agar plates were prepared for transformation with 100 mg/µL Ampicillin 
(Amp) (Appendix B). Zymo research premade Mix & Go Competent JM109 E. coli cells, 50 ml 
aliquots, (Zymo Research Corporation) were used for the transformation procedure to enable 
blue/white screening. These premade chemically competent cells ensure highly efficient and simple 
transformation, do not require heat shock procedures for the foreign DNA to enter the cells and allow 
for the foreign DNA to be added directly into the cells that can be directly spread onto the agar plates. 
Briefly, LB/Amp agar plates were set to pre-warm at 37°C for 30 minutes, then supplemented with 
X-gal (Thermo Scientific™, Randburg), 100 mg/µl Amp and 100 mM isopropyl ß-D-1-
thiogalactopyranoside (IPTG), and the plates were left to dry at 37°C. Mix & Go cells were thawed 
on ice and 2.5 µl of the ligation product was added to the cells. The cells were gently mixed and 
incubated on ice for 5 minutes. The transformation mix was spread onto the LB agar plates and the 
plates were incubated at 37°C overnight.  
For bacterial culture, a single colony/transformant was picked from the plates and mixed in 5 ml 
LB/Amp broth. The transformants were incubated at 37°C overnight shaking at 225 rpm.  
The cells were harvested by centrifugation at 4 000 rpm for 5 minutes. The pelleted cells were purified 
using the GeneJET Plasmid Mini Prep Kit (Thermo Scientific™, Randburg) following the 
manufacturer’s instructions. Briefly, the cells were resuspended in 250 µl Resuspension solution, 
thoroughly mixed and 250 µl of the Lysis solution was added to the samples. The samples were mixed 
until the solution was viscous and slightly clear and 350 µl of the Neutralization solution was added 
to the samples, and mixed again. To pellet the cellular debris, the samples were centrifuged at 13 000 
rpm for 5 minutes and the clear supernatant was applied to the GeneJET spin columns provide and 
centrifuged at 13 000 rpm for 1 minute. The samples were washed with 500 µl of Wash solution and 
centrifuged at 13 000 rpm for 1 minute. An additional centrifugation step was included to remove 
residual wash solution, and the plasmid DNA was eluted into a sterile 1.5 ml microcentrifuge tube 
with 50 µl Elution buffer (pre-warmed to 70°C). The eluted plasmid DNA was stored at -20°C for 
further analyses.  
The following amount of PCR product was used for the ligation reaction according to the ligat ion 
protocol (adapted from the Thermo Scientific™ InsTAclone™ PCR Cloning Kit): 
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Table 3. 3. Recommended amount of PCR product for the ligation reaction. 
Length of PCR product for the ligation 
reaction 
Optimal PCR product quantity for ligation reaction, 
(0.52 pmol ends) 
100 17 ng 
300 51 ng 
500 86 ng 
1000 172 ng 
2000 343 ng 
3000 515 ng 
4000 686 ng 
5000 858 ng 
3.10  Sequencing of clones generated  
The purified plasmids were sequenced using the BigDye® Terminator 3.1 Cycle Sequencing Kit 
(Thermo Scientific™, Randburg) with M13 forward and reverse primers provided in the kit. The 
sequencing reaction was set up for each primer (forward and reverse) per template following the 
modified details below: 
BigDye® Terminator v3.1 sequencing buffer 1.5 µl 
BigDye® Terminator v3.1 cycle sequencing RR 0.5 µl 
Primer (M13 forward/reverse) 1 µl 
Template (300 ng) 1 µl 
Water 1 µl 
Total volume 5 µl 
The reactions were briefly mixed and centrifuged to collect the contents at the bottom of the wells, 
and the sequencing PCR was set up following the parameters below: 
Initial denaturation  96°C 1 minute 
Denaturation 
Annealing 
Extension 
95°C 
54°C 
60°C 
10 seconds 
5 seconds           30 cycles 
4 minutes 
Hold 4°C ∞ 
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Following sequencing, the clean-up was done using the BigDye XTerminator™ Purification Kit 
(Thermo Scientific™, Randburg). Briefly, a master mix was prepared with 49 µl SAM™ solution 
and 11 µl XTerminator™ solution. The master mix was thoroughly mixed and 60 µl was added to 
each sequencing reaction. The reactions were mixed by shaking for 30 minutes and placed in the 
3130xl Genetic Analyzer system for capillary electrophoresis, selecting the suitable run module 
(“sequencing”).  
The raw data (sequenced reads/reads) obtained from the 3130xl Genetic Analyzer was imported into 
Geneious R10 software for sequence analysis which generated nucleic acid sequences for each 
plasmid. Portions of each sequence was analysed using the online database, BLAST, to determine or 
confirm the identity of the clone. Once the sequences were confirmed as containing the insert (i.e. 
virus cloned into the vector), contigs were generated with the forward and reverse reads per sample 
against the primer sequence used by selecting the “De Nova Assemble” command in Geneious R10 
and trimming the sequence with the M13 Forward and M13 Reverse primers. The contig generated 
resembled that of the insert. 
3.11  Linearization and in vitro transcription of EV plasmid DNA 
The EV plasmid DNA was linearized with EcoRI in an EcoRI restriction enzyme (RE) digestion as 
outlined below:  
10 X RE Buffer 4 µl 
Acetylated BSA 0.4 µl 
Template  1 µg 
Nuclease free water to 40 µl 
EcoRI (10 U/µl) 1 µl 
Total volume 40 µl 
The reaction was incubated as outlined below: 
Linearization 37°C  2 hours 
Enzyme inactivation 85°C 5 minutes 
Hold 4°C ∞ 
The linearized EV plasmid DNA was purified using the MiniElute Reaction Cleanup Kit (QIAGEN ®, 
Cape Town) following the manufacturer’s instructions. Briefly, the sample was mixed with 300  µl 
Buffer ERC, spun down and applied to the MiniElute columns provided. The samples were 
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centrifuged 13 000 rpm for 1 minute then washed with 750 µl Buffer PE and centrifuged at 13 000 
rpm for 1 minute. An additional centrifugation step was included at maximum speed for 1 minute to 
remove traces of Buffer PE. The linearized plasmid was eluted into a sterile 1.5 ml microcentrifuge 
tube with 10 µl Buffer EB and the purified product was stored at -20°C for further analyses. 
High yield in vitro transcription was performed on the linearized EV plasmid DNA using the 
TranscriptAid T7 High Yield Transcription Kit (Thermo Scientific™, Randburg) following the 
manufacturer’s instructions. Modifications for the protocol are outlined below:  
DEPC-treated water up to 40 µl 
5 X TranscriptAid Reaction Buffer 8 µl 
ATP/CTP/GTP/UTP mix 8 µl 
Template  1 µg 
TranscriptAid Enzyme mix 2 µl 
Total volume 40 µl 
The reaction tubes were thoroughly mixed, briefly spun down and incubated at 37°C for 2 hours. 
Following incubation, a DNase treatment was done with 2 U DNase I, RNase-free and the reactions 
were incubated at 37°C for 15 minutes.  
The RNA generated was purified using the Pure Link® RNA Mini Kit (Life Technologies™, 
Johannesburg) following the manufacturer’s instructions. Briefly, one volume of Lysis Buffer 
(prepared with 2-mercaptoethanol) was mixed with one volume of RNA, applied to the spin column 
provided and centrifuged at 12 000 rpm for 15 seconds. The sample was then washed with 500  µl 
Wash Buffer II and centrifuged at 12 000 rpm for 1 minute. An additional centrifugation step was 
included at 12 000 rpm 1 minute. The purified RNA was eluted into a sterile 1.5 ml microcentrifuge 
tube with 50 µl RNase-Free Water and stored at -80°C for further analyses. 
Determination of viral DNA/RNA copy number 
The concentrations of the EV plasmid RNA and B19 plasmid DNA were quantified using the Qubit® 
RNA Assay Kit (Life Technologies™, Johannesburg) and Qubit® dsDNA HS Assay Kit (Life 
Technologies™, Johannesburg), respectively, following the manufacturer’s instructions. Briefly, the 
reactions were set up with two standards for each sample assay. The Qubit® working solution was 
prepared in a 1:200 dilution with Qubit® RNA/DNA (specific for the kit) in Qubit® RNA/DNA 
Buffer. The modifications for the assays are outlined below: 
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 Standard 1 Standard 2  RNA/DNA sample 
Working solution 190 µl 190 µl 198 µl 
Standard 10 µl 10 µl  
Plasmid RNA/DNA   2 µl 
Total volume 200 µl 200 µl 200 µl 
Once the concentration for each plasmid was obtained, the copy number was calculated using the 
online tool, ENDMEMO (http://endmemo.com/bio/dnacopynum.php). The data for each virus such 
as sequence length (number of base pairs [bp]), weight (ng/µl) and genome structure (ssDNA, 
dsDNA, ssRNA, dsRNA) was entered into the required query field and the output generated the copy 
number per µl DNA/RNA.  
3.12  Optimization of PCR assays for viral detection using the known virus 
clones generated 
10-Fold serial dilutions were prepared from the highest copy number down to the lowest (i.e. 1x10¹) 
for each plasmid in order to determine the sensitivity of the assay. Each dilution was subjected to 
PCR amplification in order to determine the limit of detection for each assay. The Maxima HS Taq 
DNA Polymerase (Thermo Scientific™, Randburg) kit was used with minor modifications.  
The pre-nested master mix for 9 reactions per assay: 
Pre-nested 
Maxima HS Taq Buffer 23.6 µl 
Forward primer 23.6 µl 
Reverse primer 23.6 µl 
MgCl₂ 23.6 µl 
dNTP mix 4.7 µl 
Maxima HS Taq polymerase 1.2 µl 
Nuclease-free water 88.6 µl 
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20 µl of the master mix was mixed with 5 µl of each dilution (as the template) and subjected to the 
following cycling parameters:  
Initial Denaturation 95°C 4 minutes 
Denaturation 
Annealing 
Extension 
95°C 
Variable (see Table 3.2.) 
72°C 
30 seconds (40 cycles) 
Final extension 72°C 7 minutes (20 minutes for pre-cloning PCR) 
Holding 4°C ∞ 
The nested/hemi-nested master mix for 9 reactions per assay: 
Nested/Hemi-nested 
Maxima HS Taq Buffer 47.3 µl 
Forward primer 47.3 µl 
Reverse primer 47.3 µl 
MgCl₂ 47.3 µl 
dNTP mix 9.5 µl 
Maxima HS Taq polymerase 4.4 µl 
Nuclease-free water 252.8 µl 
48 µl of the master mix was added with 2 µl of pre-nested PCR product and subjected to the same 
cycling conditions outlined above. The nested PCR products were visualized by gel electrophores is 
as described in section 3.7. 
3.13  Sample collection and processing of study samples 
Heart swab samples were collected from each case during the PM investigation. Upon exposure of 
the heart, swab samples were collected from the right ventricle of the heart. This was done by singeing 
the heart surface with a spatula heated in a direct flame to create an aseptic environment, making an 
incision on the singed surface using a sterile scalpel blade and collecting the swab by rotating on the 
inside surfaces of the incision. The swab samples were stored in a tube containing universal transport 
media (UTM) upon collection. Heart tissue samples were collected from the left ventricle using a 
sterile technique, as the routine swab was collected from the right ventricle. The tissue was collected 
by making a transverse incision approximately 5 mm into the heart muscle using an ethanol sterilized 
scalpel blade and forceps. A second incision was made approximately 2 mm away from the first 
incision at the same depth, and the tissue between the two incisions was collected and placed into a 
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Tissue-Tek Uni-Cassette. The cassette was then stored in a sealed container with 10% formalin. The 
swab and tissue samples collected were transported to the Medical Virology and Forensic Pathology 
laboratories, Tygerberg campus, respectively. 
3.14  Nucleic acid extraction and quantitation 
TNA was extracted from 168 heart swab samples collected and the purity and concentration of the 
TNA were determined following the methodology described in section 3.4. Briefly, a spin column 
method was incorporated using the QIAmp® cador® Pathogen Mini Kit (QIAGEN®, Cape Town). 
The method utilizes a 15-minute lysis step, application of the lysate to the spin column for the nucleic 
acids to bind, a wash step to remove impurities and an elution step. 
3.15  Pre-nested, nested and hemi-nested PCR assay and visualization 
cDNA was generated from 5 µl TNA for all samples following the methodology described in section 
3.5. The cDNA generated and the TNA for each sample were subjected to EV and B19 viral screening 
using the Maxima Hot Start Taq DNA Polymerase (Thermo Scientific™, Randburg) kit. The EV 
plasmid RNA and B19 DNA were used as positive controls for each assay. Each positive control was 
used at its most sensitive dilution (i.e. 1x10¹) and a negative control containing only water as the 
template was also included. The pre-nested assays were first performed for all samples, followed by 
the nested and hemi-nested assays as outlined below: 
Pre-nested 
Maxima HS Taq Buffer 2.5 µl 
Forward primer 2.5 µl 
Reverse primer 2.5 µl 
MgCl₂ 2.5 µl 
dNTP mix 0.5 µl 
Maxima HS Taq polymerase 0.125 µl 
Nuclease-free water 9.4 µl 
Template  5 µl 
Total volume 25 µl 
The values above are per sample reaction. 
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Nested/hemi-nested 
Maxima HS Taq Buffer 5 µl 
Forward primer 5 µl 
Reverse primer 5 µl 
MgCl₂ 5 µl 
dNTP mix 1 µl 
Maxima HS Taq polymerase 0.3 µl 
Nuclease-free water 26.7 µl 
Pre-nested PCR product 2 µl 
Total volume 50 µl 
The cycling parameters for the assays: 
Initial Denaturation 95°C 4 minutes 
Denaturation 
Annealing 
Extension 
95°C 
Variable (see Table 3.2.) 
72°C 
30 seconds (40 cycles) 
Final extension 72°C 7 minutes (20 minutes for pre-cloning PCR) 
Holding 4°C ∞ 
The nested PCR products were visualized by gel electrophoresis as described in section 3.7. 
3.16  Histological analysis 
3.16.1.  Fixation and tissue processing 
Chemical fixation of the heart tissue was done with 10% formalin as outlined in section 3.13. Briefly, 
the tissue was placed into individual Tissue-Tek Uni-Cassettes and immersed in 10% formalin for 2-
24 hours to allow for hardening of and preservation of the tissue. Following chemical fixation, the 
cassettes were removed from the formalin and the tissue was processed using the Tissue-Tek® VIP™ 
5 Vacuum Infiltration Processor (Sakura® Finetek, Europe). This instrument functions to fixate, 
dehydrate, clear and paraffin infiltrate various types of tissue as automated system utilizing a vacuum 
and pressure source. Briefly, the Tissue-Tek Uni-Cassette containing the hardened tissue was placed 
into the resort of the instrument. The tissue was immersed in a series of alcohol solutions during the 
process of dehydration to remove most of the water from the tissue prior to wax infiltration. The 
parameters for this process are outlined below. 
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Alcohol concentration Time  
70% 1 hour  
80% 1 hour  
90% 1 hour  
100% 1 hour 3X 
Following the procession of dehydration, the tissue was immersed into xylene, a clearing agent that 
is miscible with alcohol and paraffin wax, for two cycles of 1 hour each. The clearing process ensures 
that the alcohol is completely displaced by the xylene and that large amounts of fat in the tissue is 
removed for ease of the wax to infiltrate the tissue. The final step in the process is for molten paraffin 
wax to infiltrate the tissue. During this process, the tissue is infused with hot wax in a series of four 
cycles consisting of 3 minutes each to allow the molten wax to penetrate the tissue to displace the 
xylene from the clearing process.  
3.16.2.  Wax block embedding 
Once the tissue was completely infiltrated with wax, a mould (block) was formed that can be clamped 
into a microtome for the sectioning of the tissue. The tissue specimen was placed into the mould and 
molten wax was poured over it. A cassette was placed over the mould, covered with more molten 
wax and left to solidify for 20 minutes. The wax block was clamped to a microtome and sectioned/cut 
at 3-4 µm thickness. The section was floated out in a water bath (set between 50-55°C, i.e. below the 
melting point of the wax) and picked up on a positive charged glass slide. The slide was placed in an 
incubator at 70°C for 15 minutes to melt down excess wax around the tissue and for the tissue to 
adhere to the slide.  
3.16.3.  Haematoxylin and eosin (H&E) staining 
H&E staining was done using the Stainer coverslipper which is an automated Tissue-Tek film 
machine. The first process allowed for rehydration of the tissue. The slide was immersed into xylene 
for a series of three cycles of 5 minutes each, followed by a series of immersion in alcohol solutions 
as outlined below. 
Alcohol concentration Time  
100% 1 hour 3X 
96% 1 hour  
70% 1 hour  
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The slides were immersed in tap water for a rinsing step and then immersed in Mayers Haematoxylin 
for 10 minutes to stain the nuclei of the cells. Another rinse step was included. The slide was 
immersed in 1% Lithium carbonate for 1 minute to intensify the colour of the haematoxylin. The slide 
was then counterstained in Eosin-yellowish solution, an acidic solution that stains basic parts of the 
cell, such as the cytoplasm. A final wash step was included. The final step included the dehydration 
of the tissue on the slide by immersion in a series of alcohol and xylene cycles as outlined below. 
Reagent Time  
70% alcohol 5 minutes  
96% alcohol  5 minutes  
100% alcohol 5 minutes 3X 
Xylene 5 minutes 3X 
Histological processing was conducted in the Division of Forensic Medicine by Mr André du Toit 
and Mr John Segole, Chief Forensic Technologist and Medical Technologist, respectively. The 
protocol for histological processing was obtained by direct communication from Mr André du Toit. 
3.17  Reviewing of case file information and routine laboratory results  
Available sociodemographic data and clinical history for each SUDI case were obtained from the 
case files and questionnaires, Appendix C, (answered by the parent, family member or friend at the 
time of admitting a case to the Tygerberg Medico-legal Mortuary) for the cases included in this study. 
The data was captured onto a Microsoft® Excel® spreadsheet for statistical analyses. Information such 
as age, race, birth weight, date of birth and death, infant sleeping position, parental smoking and 
drinking habits, COD classification as assigned by the forensic pathologist based on a thorough PM 
investigation (which may have included DSI, autopsy and clinical history review), etc. were included 
in the data analysis sheet. 
3.18  Statistical analysis 
Statistical analysis was performed using R software version 3.4.1. Categorical variables were 
summarized using proportions and frequencies. To measure the strength of the association between 
groups, odds ratio and its 95% confidence interval (CI) were computed using simple logist ic 
regression analysis.  
The dataset was stratified according to gender, season (warm and cold) and COD (only Infection and 
SIDS) as major risk factors according to the literature.  Categorical variables were compared between 
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the two groups using the Chi-square test or the Fisher exact test. Numerical variables were compared 
between the same groups using the two sample Wilcoxon test or student t-test when required. 
Sensitivity and specificity tests were used to evaluate the EV and B19 PCR assays developed against 
histology as the gold standard in the diagnosis of myocarditis. 
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CHAPTER FOUR  
RESULTS 
4.1  Introduction 
This study aimed to profile EV and B19 in prospective SUDI samples collected over a period of one 
year (July 2016 – July 2017). Two PCR-based assays were designed for the detection of EV and B19 
nucleic acid in heart swab samples and were compared to microscopic features of infection in heart 
tissue samples. Routine microbiology of the heart and HIV screening results were also obtained and 
incorporated into the study. Clinical and sociodemographic data were obtained from the case files 
and assessed to identify possible risk factors associated with these SUDI cases. 
4.2  Population characteristics 
A total of 168 SUDI cases were included in the study over the one-year period with a male to female 
ratio of 1:1.07. This sample number was lower than those shown in section 2.7 (Figure 2.6) as it did 
not include ALL the SUDI cases (N=210) admitted to the mortuary over this study period and the 
selection criteria used in this study was different to that of the cases in section 2.7. During the study 
period, only black and coloured infants were admitted to the Tygerberg Medico-legal Mortuary as 
SUDI, with the majority of cases being black (n=107, 64%). The majority of deaths occurred during 
the colder months of the year (75 in winter and 37 in autumn; or 67% combined) (Figure 4.1). The 
mean birth weight of the infants was 2 463.98 g (standard deviation [SD]: 809.06 g). The median age 
of the infants at the time of death was 10.9 weeks (interquarti le range [IQR]: 6.25 - 17.32). The 
majority of infants were aged between 1 and 13 weeks at the time of death (n=107, 64%), with a peak 
between 9 and 13 weeks old (n=44, 26%) (Figure 4.2). The median post-mortem interval (PMI), 
which is the interval between the date of death and the date of autopsy, was observed as 5 days (IQR: 
3 - 7).  
A total of 29 (18%) and 50 (31%) infants were exposed to alcohol and tobacco smoke during 
pregnancy respectively, and 15 (11%) were exposed to tobacco smoke postnatally. 
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Figure 4.1. Sociodemographic data in the SUDI population. 
 
Figure 4.2. Age distribution of infants at time of death. 
Details about the infants’ sleep enviroment are denoted in Figure 4.3. The majority of infants (n=88, 
56%) resided in informal housing enviroments and a significant proportion (n=144, 96%) slept in a 
bed with one or more individuals. A total of 33 (21%) infants sleep in non-ventilated rooms. The 
majority of infants were put to sleep (n=90, 64%) and found dead (n=67, 49%) on their sides.  
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Figure 4.3. Housing and sleep-related practices in the study population. 
Out of a total of 168 cases, clinical symptoms prior to demise were observed in 36 cases (23%). 
Microscopic signs of myocardial infection were observed in 10 cases (6%), in which 1 (20%) case 
showed macroscopic abnormalities (Case 122) where the coronary arteries were patent and the left 
ventricular wall of the heart displayed a mottled appearance. Specific bacteria and viruses were 
confirmed in 39 (23%) and 162 (96%) SUDI cases respectively.  
 
Figure 4.4. Clinical and laboratory findings for the SUDI cases. 
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4.3  COD classification 
The final COD for the SUDI cases was assigned by the Forensic pathologists at the Tygerberg 
Medico-legal Mortuary following the completion of the PM investigation, which included reviewing 
of the clinical history and death scene (may not have been performed in all cases) and a full autopsy 
examination. Only a total of 121 (72%) SUDI cases were assigned a final COD at the time of 
statistical analyses, while the remainder are still under investigation. The final COD was classified 
into three groups (Figure 4.5), namely infection (n=64, 53%), SIDS (n=48, 40%) and other (n=9, 7%). 
Other constituted death due to acute aspiration (n=2), asphyxia (n=1), congenital heart conditions 
(n=2) and undetermined by autopsy i.e. where an unnatural cause could not be ruled out or where 
there was insufficient information to ascertain a definite cause of death (n=4). 
 
Figure 4.5. The final COD classification for the SUDI cases. 
4.4  Routine microbiology analysis of the heart 
Bacterial culture on the specimens collected from the heart, one of the routine tests for SUDI cases at 
Tygerberg Medico-legal Mortuary, was included in the study. Bacteria was detected in only 39 (23%) 
SUDI cases. E. coli and S. aureus, pathogens commonly identified in SUDI cases, were detected in 7 
(4%) and 3 (2%) SUDI cases respectively. Post-mortem and normal skin flora were detected in 12 
(7%) and 5 (3%) cases respectively (Table 4.1). Streptococcus pyogenes (1 case), PM flora (1 case), 
E. coli (2 cases), Streptococcus pneumoniae (1 case), Klebsiella pneumonia (1 cases), Enterococcus 
facieum (1 case) and Enterococcus faecalis (1 case) were detected in the cases in which clinica l 
n=64, 53%
n=48, 40%
n=9, 7%
Infection SIDS Other
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symptoms were observed prior to death. Positive microbiology results were found in 16 (41%) cases 
where infants were exposed to tobacco smoke either in utero and/or postnatally, 8 (21%) cases where 
infants slept in non-ventilated rooms, 30 (77%) cases in which the practice of bedsharing was 
observed and 10 (26%) cases in which infants were put to sleep or found dead on their stomach. In 
27 (69%) cases where the PMI exceeded 4 days (median 6 days, range 5 – 12 days), PM flora was 
confirmed in 8 cases, E. coli in 5 cases, normal skin flora in 4 cases, Klebsiella pneumonia in 2 cases 
and S. aureus, Enterococcus species, Streptococcus agalactiae, group B Streptococcus, Serratia 
liquefaciens, Enterococcus faceuim and Enterococcus faecalis in 1 case each.  
Table 4.1. Bacteria isolated from heart. 
Microbiology Frequency (n) Percentage (%) 
Coagulase negative Staphylococcus 1 0.6 
Enterobacter cloacae 2 1.1 
Enterococcus faceuim 1 0.6 
Enterococcus faecalis 1 0.6 
Enterococcus species 1 0.6 
E. coli 7 4.1 
Klebsiella pneumoniae  2 1.1 
No growth 128 76.1 
Normal skin flora 5 2.9 
Post-mortem flora 12 7.1 
Serratia liquefaciens 1 0.6 
S. aureus 3 1.7 
Streptococcus agalactiae 1 0.6 
Group B Streptococcus 1 0.6 
Streptococcus pneumoniae 1 0.6 
Streptococcus pyogenes 1 0.6 
4.5  Routine HIV testing 
Peripheral blood was available for only 160 SUDI cases and sent to the NHLS Medical Virology 
laboratory for the rapid detection of antibodies against HIV 1/2. A total of 36 (23%) of these SUDI 
cases was positive for HIV 1/2 antibodies from the whole blood samples.  
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4.6  Histology 
A total of 161 SUDI cases were included for histologic analysis of the heart tissue collected and 
processed, while no tissue samples were available for the other 7 cases. In the majority of the cases 
(n=151, 94%) no remarkable signs of infection were observed in the myocardial tissue and in these 
cases the histology was classified as “normal”. Signs of infection were considered when features of 
inflammation and/or myocytolysis (such as infiltration of inflammatory cells, abnormal myocytes and 
eosinophils) were observed (Table 4.2). An example of the microscopic features of myocardia l 
infection is depicted in Figure 4.6, where infiltration of inflammatory cells and myocytolysis were 
observed in the myocardial tissue for one of the SUDI cases.  
Table 4.2. Microscopic features observed in the heart tissue for the SUDI cases. 
SUDI case Histology 
Case 015 Diffuse inflammation consisting of chronic inflammatory cells including lymphocytes and 
plasma cells, myocytolysis 
Case 032 Mild chronic inflammation 
Case 039 Focus of chronic inflammation with very mild and focal myocytolysis 
Case 040 Area of myocytolysis, not considered artefact 
Case 045 Very focal acute inflammatory cells, neutrophils and scant eosinophils in myocardium 
associated with blood vessels, with virtually no manifestation of myocytolysis 
Case 050 Cellular interstitium consisting of mixed inflammation, interstitial edema. Relatively focal 
inflammation, and myocardium relatively spared 
Case 122 Chronic inflammation, myocytolysis 
Case 123 Mixed inflammation, but predominantly chronic 
Case 127 Chronic inflammation, mild myocytolysis 
Case 144 Focal parenchymal hemorrhage, myocytolysis 
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Figure 4.6. Microscopic features of inflammation in the myocardium. Red arrow shows infiltration of chronic 
inflammatory cells and myocytolysis (SUDI Case 122; magnification ×100) 
4.7  PCR assays 
Two PCR assays were designed for the detection of B19 and EV nucleic acids respectively using the 
generated plasmids described in Chapter 3 as positive controls for the assays. The copy numbers for 
the EV and B19 plasmids were determined as 133.65 and 145.33 copies/µl, respectively, at the lowest 
detection limit. The B19 DNA and EV cDNA for 168 SUDI cases were amplified by nested/hemi -
nested PCR and separated by 2% agarose gel electrophoresis (Figure 4.7) to produce bands of 173 bp 
and 196 bp respectively (indicated by the red arrows). 
Stellenbosch University  https://scholar.sun.ac.za
41 
 
Figure 4.7. Detection of B19 and EV by Nested PCR.  
(a) EV PCR, Lanes 1: 50bp DNA ladder, 2: positive control, 3: SUDI case sample, 4: negative control.  
(b) B19 PCR, Lanes 1: 50bp DNA ladder, 2: negative control, 3: positive control, 4: SUDI case sample.  
The complete PCR results are listed in Appendix D. In summary, a total of 161 (96%) and 50 (30%) 
positive amplicons were detected for B19 and EV respectively. Both B19 and EV were detected in 
49 (29%) cases. 
Sequencing of 8 random gel purified (Appendix E) B19 positive amplicons were performed following 
the protocol in section 3.11 using 3.2 µl forward and reverse B19 primers. Contigs were generated 
for each sequenced amplicon and the contigs were aligned to the sequence of the positive control in 
a multiple sequence alignment in Geneious R10 software. No exact match was observed in any of the 
sequences and the identity was confirmed as highly related to B19 isolates using the BLAST online 
software tool.  
4.8  Statistical analyses 
Categorical variables were summarized using proportions and frequencies. Median and IQR were 
used to summarize numerical data where kurtosis or skew distribution was evident. Mean and SD 
were used for numerical data displaying a normal distribution. The strength of an association between 
two groups were measured by Odds Ratio (OR) and its 95% CI. 
4.8.1.  Sensitivity and specificity tests for PCR assays 
The sensitivity and specificity for the two PCR assays designed were calculated to determine the 
diagnostic value of the assays against histological analysis as the gold standard for diagnosis of 
myocardial infection. The sensitivity was calculated using the true positive (TP) and false negative 
(FN) values for each assay and the specificity was calculated using the true negative (TN) and false 
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positive (FP) values for each assay (Tables 4.3 and 4.4). Sensitivity of an assay refers to its false 
positive rate i.e. the probability that the assays will yield a positive result in the presence of a certain 
pathogen, while specificity is the false negative rate or the probability of the assay to yield a negative 
result in the absence of a certain pathogen. Sensitivity and specificity of the PCR assays developed 
were calculated as 44% and 73% respectively for B19 and 89% and 3% respectively for EV using the 
equations below. The sensitivity and specificity of each assay was used to calculate the likelihood 
ratio (LR) in order to determine the likelihood that the PCR result is correct to the likelihood that the 
PCR result is incorrect using the equation below (LR + is the likelihood of a positive PCR result) . 
The positive LR for B19 assay according to the calculation is +1.65, which would indicate that an 
infant is about 1.65 times more likely to have a positive B19 PCR result when myocardial infect ion 
is present than in the absence of myocardial infection. Similarly, for the EV assay, an infant is about 
0.92 times more likely to have a positive EV PCR result when myocardial infection is present than in 
the absence of myocardial infection. 
Table 4.3. Two-table contingency test for B19 assay against histology. 
PCR (as test in question) Histology (as golden standard) 
 Positive Negative 
B19 positive 4 41 
B19 negative 5 111 
Sensitivity = 
𝑇𝑃
𝑇𝑃+𝐹𝑁
=
4
4+5
= 44.44% 
Specificity = 
𝑇𝑁
𝐹𝑃+𝑇𝑁
=
111
41+111
= 73.03% 
LR+ = 
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
1−𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦
=
0.44
1−0.73
= 1.65 
Table 4.4. Two-table contingency test for EV assay against histology. 
PCR (as test in question) Histology (as golden standard) 
 Positive Negative 
EV positive 8 147 
EV negative 1 5 
Sensitivity: 
𝑇𝑃
𝑇𝑃+𝐹𝑁
=
8
8+1
= 88.89% 
Specificity: 
𝑇𝑁
𝐹𝑃+𝑇𝑁
=
5
147+5
= 3.29% 
LR+ = 
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
1−𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦
=
0.88
1−0.03
= 0.92 
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4.8.2.  Histology, clinical history and viruses detected by PCR 
The clinical history was compared to the viruses detected in the 10 SUDI cases with histologica l 
features of infection. Clinical symptoms of infection, such as fever, runny nose and vomiting prior to 
death, were present in 4 of these cases (Table 4.5).  
4.8.3.  Comparison of histology, final COD, virology, microbiology and HIV status 
Although features of myocarditis were observed microscopically in 10 SUDI cases, the final COD as 
myocarditis was assigned in only 1 SUDI case (Case 015). Both B19 and EV DNA were detected in 
this case. In another SUDI cases, Case 123, B19 and EV were absent although features of 
inflammation in the myocardium were present (Table 4.6). 
4.8.4.  Gender, seasonality and final COD and the viruses detected by PCR 
In contrast to the male predominance in SUDI observed in the literature, no significant association 
between a positive PCR result and the gender of the infants was observed in this study (Figure 4.8). 
Similar to the literature, a higher proportion of viruses were detected during the cold months (n=74, 
44% in winter and n=35, 21% in autumn; combined n=109, 65%; Figure 4.9) and in infants that died 
as a result of infection (n=64, 53%; Figure 4.10), however neither were statistically significant. 
Table 4.5. Clinical history and viruses detected in the ten SUDI cases with histological features of myocarditis.  
SUDI case Histology (features of 
infection) 
Clinical history Virus 
Case 015 Inflammation, myocytolysis Fever, coughing, seizures  B19, EV 
Case 032 Inflammation  B19 
Case 039 Inflammation, myocytolysis  B19, EV 
Case 040 Myocytolysis  B19, EV 
Case 045 Inflammation Runny nose B19, EV 
Case 050 Inflammation  B19, EV 
Case 122 Inflammation, myocytolysis History of lung infection B19 
Case 123 Inflammation   
Case 127 Inflammation, myocytolysis Vomiting when fed B19 
Case 144 Myocytolysis  B19 
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Table 4.6. Summary of SUDI cases with histological features of myocarditis as determined by microscopic 
analysis of myocardial tissue and COD, viral, bacterial and HIV screening. 
SUDI 
case 
Histological 
signs of infection 
COD assigned by 
pathologist 
Virology Microbiology HIV 
Case 015 Yes (I, M) Myocarditis ++ No growth Negative 
Case 032 Yes (I) Pneumonitis + No growth Positive 
Case 039 Yes (I, M) SIDS ++ No growth Negative 
Case 040 Yes (M) Under investigation ++ No growth Positive 
Case 045 Yes (I) Interstitial pneumonia ++ No growth Negative 
Case 050 Yes (I) LRTI ++ No growth Negative 
Case 122 Yes (I, M) Under investigation + E. coli Negative 
Case 123 Yes (I) Under investigation - No growth Positive 
Case 127 Yes (I, M) LRTI + No growth Negative 
Case 144 Yes (M) SIDS + PM flora Insufficient 
specimen 
I – inflammation, M – myocytolysis, LRTI – Lower respiratory tract infection, ++ (B19 & EV positive), + 
(B19 positive) 
 
Figure 4.8. Viruses detected by PCR between male and female infants. 
n=80, 48%
n=1, 0%
n=82, 49%
n=5, 3%
Male (Positive PCR) Male (Negative PCR) Female (Positive PCR) Female (Negative PCR)
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Figure 4.9. Viruses detected by PCR across the different seasons of the year.  
 
Figure 4.10. Viruses detected by PCR within the final COD category. 
n=22, 13%
n=1, 1%
n=74, 44%
n=1, 1%
n=35, 21%
n=2, 1%
n=31, 18%
n=2, 1%
Summer (Positive PCR) Summer (Negative PCR) Winter (Positive PCR) Winter (Negative PCR)
Autumn (Positive PCR) Autumn (Negative PCR) Spring (Positive PCR) Spring (Negative PCR)
n=64, 53%
n=0, 0%
n=47, 39%
n=1, 1%
n=8, 6%
n=1, 1%
Infection (Positive PCR) Infection (Negative PCR) SIDS (Positive PCR)
SIDS (Negative PCR) Other (Positive PCR) Other (Negative PCR)
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4.8.5.  Population characteristics categorized by final COD (excluding Other) 
Risk factors associated with SUDI in the literature were compared between SIDS and infection for 
categorical (Table 4.7) and numerical data (Table 4.8). A p-value less than 0.05 was regarded as 
statistically significant. The results identified black infants to have a 2.36 odds of SUDI being 
attributed to infection (p = 0.028). This is however not clinically relevant because the referral area of 
the Tygerberg Medico-legal Mortuary does not represent the true demographic distribution in the 
general population. Furthermore, no other differences that may show statistical significance were 
identified  in the COD categorization. 
Table 4.7. Population characteristics categorized by COD. 
Characteristics SIDS, N (%) Infection, N (%) p-value OR 95% CI 
Gender 
Male  21 (43.8) 35 (54.7) 0.251 1.55 0.73 – 3.32 
Female  27 (56.2) 29 (45.3)    
Race 
Black 24 (50.0) 45 (70.3) 0.028 2.36 1.09 – 5.22 
Coloured 24 (50.0) 19 (29.7)    
Season 
Autumn 9 (18.8) 12 (18.8) 0.769 1.33 0.34 – 5.29 
Spring 10 (20.8) 10 (15.6)  1.00 0.25 – 3.97 
Winter 22 (45.8) 35 (54.7)  1.59 0.48 – 5.25 
Summer 7 (14.6) 7 (10.9)    
Housing 
Informal 21 (45.7) 38 (62.3) 0.080 1.96 0.90 – 4.32 
Formal 25 (54.3) 23 (37.7)    
Ventilation in bedroom 
Yes  39 (84.8) 46 (78.0) 0.377 0.63 0.21 – 1.71 
Bed sharing 
Yes  41 (97.6) 56 (93.3) 0.646 0.34 0.01 – 2.41 
Position put to sleep 
Back 4 (9.5) 6 (10.9) 0.524 0.79 0.17 – 3.78 
Side  29 (69.0) 32 (58.2)  0.58 0.21 – 1.48 
Stomach 9 (21.4) 17 (30.9)    
Position found (dead) 
Back 12 (29.3) 9 (18.0) 0.398 0.45 0.13 – 1.46 
Side  20 (48.8) 26 (52.0)  0.78 0.27 – 2.12 
Stomach 9 (22.0) 15 (30.0)    
In utero tobacco exposure  
Yes  18 (38.3) 20 (32.8) 0.552 0.78 0.35 – 1.74 
Postnatal tobacco exposure 
Yes  4 (10.8) 6 (11.3) 1.000 1.05 0.27 – 4.39 
In utero alcohol exposure 
Yes  9 (19.1) 11 (18.0) 0.882 0.92 0.34 – 2.51 
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Table 4.8. Population characteristics categorized by COD. 
Characteristics SIDS Infection p-value 
Birth weight* 2458.02 2625.31 0.279 
Age (weeks)† 9.65 11.15 0.726 
Maternal age (years) † 27.50 28.00 0.599 
* Mean 
† Median 
 
  
Stellenbosch University  https://scholar.sun.ac.za
48 
CHAPTER FIVE  
DISCUSSION 
5.1.  Introduction 
SUDI has been an important topic of interest for centuries, and there is very limited information 
available in Africa (Ibeziako et al. 2009). SIDS is one of the main causes of infant death worldwide, 
alongside congenital abnormalities, prematurity and low birth weight (Goutas et al. 2011). Infection 
remains a common contributor to SUDI, but SIDS rates remain high, especially among infants in 
developing countries (Ndu 2016). Our findings agree with that of Weber et al. (2008b) where 63% 
of their SUDI cases remained unexplained and of the 37% explained deaths, more than half (58%) 
were attributed to infection.  
We used a cross-sectional study to investigate the association between 168 SUDI cases and 
myocarditis. A small proportion of cases showed histological signs consistent with myocardia l 
infection, but a final diagnosis or COD of myocarditis was only made in one case.  
5.2.  Population characteristics and demographics 
Male gender is an important risk factor frequently reported in SIDS. Mage and Donner (2014) 
reported that males are more susceptible to respiratory infection during infancy, possibly contributing 
to the overall male predominance found in SIDS. Mage and Donner (2009) reported a male to female 
ratio of 1:0.61 for SIDS cases in the USA, which is slightly lower than 1:0.82 observed in South 
Africa between 2005 and 2009 (du Toit-Prinsloo et al. 2013). However, the male to female ratio in 
our study (1:1.07) did not agree with trends in the literature. Instead, we observed slightly more 
females than males, which was similar to a previous study (unpublished), 1:0.03, done at the 
Tygerberg Medico-legal Mortuary between 2015 and 2017. The reason for this difference is not 
known.  
Male circumcision might be associated with the male predominance in previous SIDS studies (Elhaik 
2016), however, this hypothesis needs to be tested in a non-biased setting (e.g. where circumcision is 
observed in both male and female infants). We do not consider circumcision as a possible risk factor 
for SIDS in our setting, as circumcision of males is a traditional and cultural practice that occurs much 
later in life (teenage period) and none of the male infants included in this study were circumcised at 
the time of autopsy (personal observation). Therefore, the gender discrepancy found between our 
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cases and the literature needs to be further investigated in future prospective studies or extensive 
retrospective case file audits. 
Two-thirds of our cases occurred during the colder months, consistent with the published peak 
incidence during winter and decrease in the warmer months. Respiratory infections are common in 
winter and circulation of respiratory pathogens can easily be transmitted to infants by household 
contacts or in close contact environments, such as day care (Mage 2004; Mage et al. 2016). 
The 2 to 4 month peak age reported in the literature (Hakeem et al. 2015) is similar to the 9 to 13 
week peak found in our study. An association between the peak age in SIDS and the age at which 
maternally-acquired antibodies are decreased or completely lost have previously been described, 
indicating increased susceptibility to infection, leading to increased infant vulnerability. Although 
infant immunization is initiated around this period of vulnerability (6 weeks), infants are not fully 
vaccinated against common illnesses encountered in childhood and the infant immune system is still 
regarded as functionally immature (Hoffman et al. 1987; Waaijenborg et al. 2013).  
Several studies have reported on bed sharing, such as Hauck et al. (2003) who reported a 50% 
incidence and Blair et al. (2009) who also reported more than half of their study population sharing 
a bed with another person.  However, this is much lower than the 96% observed in our study. We 
postulate that this might be a result of poverty (56% of infants reside in informal living conditions) 
and also high parity found in our study, where the number of beds in the household might be lower 
than the number of individuals in the household (Ball et al. 2012). An early study conducted in New 
Zealand found that bed-sharing was present in both Maori and non-Maori populations, however only 
among Maori infants was bed-sharing related to increased risks in SIDS (Mitchell et al. 1993). This 
finding needs further elucidation in the broader South African population to investigate possible 
correlations between specific ethnic groups and the risk of SUDI. 
The most common sleeping position in which infants were placed was on their sides, however, fewer 
cases were found on their sides. It has been proposed that this is in fact the most unstable position 
(Ibeziako et al. 2009), because infants can easily roll over to another position during the night and 
succumb to SUDI due to other external stressors. Despite this theory, the side sleeping position is still 
considered safer than the prone position. 
According to the surveys in the case file reports in our study, only 18% and 31% of infants were 
exposed in utero to alcohol and tobacco respectively. May et al. (2014) showed that 88 - 91% of 
mothers who have infants with Fetal Alcohol Spectrum Disorders consumed alcohol during 
pregnancy and up to 70% reported binge drinking, which is regarded to be much more harmful to the 
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developing infant. Additionally, 74% of mothers smoked during pregnancy and 67% reported a 
combination of smoking and drinking, which are both known risk factors for SUDI. The differences 
between our data and that of May et al. (2014) can partly be ascribed to the fact that their survey was 
done in mothers with living infants. However, in utero exposure to alcohol and tobacco increases the 
risks of SIDS (Hakeem et al. 2015) by jeopardizing fetal development and thereby increasing the 
vulnerability of the infant after birth (Blair et al. 2009). Although smoking and drinking during 
pregnancy are some of the most obvious modifiable lifestyle changes that should be advocated, it 
would require much larger case-control studies in order to confirm smoking and drinking during 
pregnancy as independent risk factors for SUDI. However, due to ethical constraints, we are not able 
to include any control cases at this stage. 
5.3.  Routine microbiology testing 
PM microbiology analysis is important in SUDI investigation as it provides valuable information 
about whether infection can be implicated in death and can also describe the role and presence of 
nosocomial bacteria in a specific hospital environment (Tsokos & Püschel 2001). However, possible 
contamination with PM flora often challenges the value of microbiological culture in PM cases. The 
presence of bacteria in an organ should not necessarily be regarded as the COD, as it often only 
indicates the presence of these pathogens at the time of death (Eisenfeld et al. 1983; Aranda et al. 
1998; Rambaud et al. 1999). It is therefore imperative to supplement these results with ancillary tests 
or investigations. 
In our study, although bacterial growth was observed in 39 SUDI cases, the majority were attributed 
to PM flora, followed by a few cases of E. coli. Similar to the findings of Weber et al. (2010b), we 
could not demonstrate any association between increased PMI (> 4 days) and positive bacterial 
culture.  
The risk of prone sleeping, excessive bedding/wrapping and presence of viral infection have 
previously been associated with colonization by Streptococcus pyogenes and release of toxins 
(Blackwell et al. 1995). Our study also identified Streptococcus pyogenes in one of our cases and we 
postulate that other factors, such as a non-ventilated bedroom, bed-sharing and the presence of B19 
and EV DNA observed in this case, might have potentiated the growth of this bacterium. The 
histology in this case was normal and a final COD has unfortunately not yet been assigned by the 
pathologist at the time of statistical analyses. It would be important to follow up on this case once it 
is finalized and incorporate the findings in the development of a standardized institutiona l 
investigation protocol for SUDI at the Tygerberg Medico-legal Mortuary. 
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5.4.  Viral detection by PCR 
A number of reports in the literature demonstrate the association between SUID and viruses often 
implicated in myocarditis (Bowles et al. 2003; Dettmeyer et al. 2004, Dettmeyer et al. 2008; Uhl 
2008; Dettmeyer et al. 2009). In the past, EV has been reported as an important cause of viral 
myocarditis, however B19 is currently also emerging as a causative agent (Canter & Simpson 2014).  
We designed two PCR assays to detect two viruses that are commonly associated with myocardit is, 
i.e. EV and B19. EV DNA was detected by PCR in 30% of our cases, which was comparable to the 
22.5% EV detected in a German SUDI population (Weber et al. 2008a), but contrasted the find ings 
of 0% EV detected in SIDS cases from California in the USA (Krous et al. 2009). The literature 
suggests that EV DNA is detected less often in myocardial samples (Mahfoud et al. 2011; Nielsen et 
al. 2014) than previously shown (Martin et al. 1994). Our study was only able to confirm the presence 
of both EV DNA and histological signs of inflammation in five cases (Appendix E). 
We observed a very high prevalence of B19 DNA in the myocardial swab samples and we confirmed 
these results TP by sequencing analyses. Schenk et al. (2009) also identified a very high prevalence 
of B19 in their study in myocardial samples with positive serology for B19 infection. However, 
Dettmeyer et al. (2004) detected a much lower frequency for B19 in SIDS cases. B19 is widespread 
in humans although it may not always be related to active infection. A study done by Nielsen et al. 
(2014) supports this, where they found that B19 viral DNA, detected by PCR, was present in autopsy 
samples from both myocarditis cases as well as non-myocarditis control heart tissue. They suggested 
that the presence of B19 in their myocardial samples were rather related to latent or persistent 
infection that might have occurred earlier in life based on positive IgG titres in 63% of their cases, 
and positive IgM titres in only one case related to B19 infection. Reports by other authors show 
similar contradicting findings of B19 prevalence (Bültmann et al. 2003; Donoso Mantke et al. 2004; 
Schenk et al. 2009; Koepsell et al. 2012).  
5.5.  Final COD in SUDI cases 
Diagnosis of the final COD in the SUDI cases in our study were based on the integration of all PM 
details and autopsy findings, but histological analyses, and specifically evidence of myocardit is, 
weighed heavily in the determining of the diagnosis. Radiology, SVC in lung and liver tissue for 
detection of selected respiratory pathogens (as described in section 2.6), bacterial detection (lungs 
and heart), rapid HIV and U&C testing were additional diagnostic tests that potentially contributed 
to or supported the diagnosis of the COD.  
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The findings observed in Table 4.6 challenge the validity of using histology independently in 
diagnosing the final COD in SUDI cases. Although features resembling myocardial inflammation 
were apparent microscopically, and either one or both of the viruses investigated were detected in 
90% of these cases, there was only one case in which the diagnosis of fatal myocarditis was 
established based on histopathology alone.  
Our study suggested that the reliability and sensitivity of independent histopathological assessment 
as a solitary tool to diagnose myocarditis, without utilising ancillary techniques such as microbio logy 
or virology, may be questionable. Tissue sampling for histological assessment may affect the outcome 
of diagnosis of myocarditis, given that the assessment and interpretation is limited to the section of 
analysis, which may not represent the entire area of inflammation. Gaaloul et al. (2016) illustra ted 
the effectiveness of using molecular-based techniques in combination with histology to diagnose viral 
causes in SIDS. Incorporation of molecular-based techniques has been encouraged to reduce, if not 
eliminate, suboptimal or incorrect diagnosis of sudden infant death (Arnestad et al. 2002; Dettmeyer 
et al. 2002) or any infectious COD. 
Interpretation of a positive viral PCR result in the absence of histological signs of active infection is 
extremely difficult and challenging. For the B19 assay, we observed a relatively higher specific ity 
(73%) than sensitivity (44%). This means that the FN rate of the method was 27% where positive 
B19 amplicons were not detected. We also observed a fairly high sensitivity (89%) for the EV assay,  
but an extremely suboptimal specificity (3%), suggesting an unacceptably high FP rate of 97%. Any 
diagnostic test aims to have sensitivity and specificity rates as close to 100% as possible; so much 
more for SIDS, for reasons such as feasibility, safety and cost-effectivity. Whether or not high 
sensitivity or specificity rates are achieved, is determined by the disease in question, the diagnost ic 
standard used for the disease and the implications of the results (Hazra & Gogtay 2017). Comparing 
the assays to histology suggests that the B19 assay has an advantage over the EV assay at predicting 
the mere presence of a virus, not necessarily causing infection or death, and highlights the idea that 
there may be discrepancies in diagnosing myocardial infection – and possibly affecting the final COD. 
Respiratory viruses are often isolated in SIDS cases (Raza & Blackwell 1999). In our study, infect ion 
was implicated in just over 50% of deaths and respiratory-related infections were the leading COD. 
In only three of our cases assigned a final COD of respiratory-related infection, features of 
inflammation and/or myocytolysis and the presence of one or both viruses were also observed.  
No other cause of death could be ascertained in a large proportion (40%) of our cases and were being 
classified as SIDS. This finding agrees with Weber et al. (2008a) who found a slightly higher 
proportion of SUDI (60%) classified as SIDS, although du Toit-Prinsloo et al. (2013) only found 
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between 9% and 15% of cases classified as SIDS. Nonetheless, our findings highlight the need of 
incorporating alternative or additional tests in SUDI investigations, especially since no standard 
international guidelines exist. 
5.6.  Limitations & Recommendations 
The main limitation in our study was the absence of a control group for comparison to add secondary 
value to the findings. Ethical consideration for collection of heart samples from living individua ls 
may not easily be granted, as it is regarded as unethical and unacceptable practice. Additiona lly, 
ethical consideration for collection of samples from deaths from non-natural causes is also 
prohibitively difficult, due to the fact that this study was performed with a waiver of consent. Hence, 
the only comparisons we could make for the findings observed in our study was to similar find ings 
published in the literature that were able to include control groups into their studies. 
Another limitation in our study was that we were unable to profile all of the main viruses (such as 
CVB, HAdV, EBV, CMV, HHV6) associated with myocarditis due to time and financial constraints. 
Hence, this is recommended as a future study. 
No tests were also conducted to determine the pathogenicity of the bacteria detected, although we 
know from the literature that S. aureus (Zorgani et al. 1999; Highet et al. 2009) and E. coli 
(Bettelheim et al. 1990; Pearce et al. 2010) are toxigenic bacteria. No additional tests were also 
performed to determine whether bacteria (such as E. coli for example) consisted of pure or mixed 
cultures. The additional tests are not part of the standard facility investigation protocol for SUDI cases  
and financial restraints did not allow further testing.  This should also be addressed in future studies. 
The timing of this study (when the study and write-up was concluded) served a minor disadvantage 
in terms of including the final COD for ALL cases into the data analysis, as a few cases (28%) were 
still under investigation at the time of this writing. This may have limited the interpretation of the 
results related to COD to some extent. Hence it is recommended to review the cases with a final COD 
as ‘under investigation’ and incorporate the results into the statistical analyses for latter publicat ions 
of this study. 
To our knowledge, this was the first study in South Africa to profile B19 and EV in myocardia l 
samples in SUDI cases. The benefit of this study is that:  
i) It serves as a foundation for the awareness of myocardial inflammatory and infectious conditions 
in the South-African medico-legal environment, 
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ii) It can potentially contribute significantly to the implementation of a national standardized SUDI 
investigation protocol in which myocardial infectious pathology has a rightful place, 
iii)  It can potentially focus the sights of the forensic pathology fraternity on the benefits of full testing 
for myocardial infectious conditions, 
iv) The data and knowledge obtained from this study may have significance in the clinical field, as 
specific findings from PCR screening assays for cardiovascular viruses will be reported at Child 
Death Review for a where clinicians and epidemiologists in attendance may implement clinica l 
protocols for the early diagnosis and treatment of ill children. 
With regards to the B19 PCR assay results, further research is necessary to investigate other factors 
that may have contributed to the high prevalence of B19 observed in our study. 
Other recommendations pertaining to some of the data obtained in this study include investigating: 
i) population data and other data for infants within the same age group as in our study in order to 
investigate possible reason for the slight change from male predominance, 
ii) the accuracy of the data reported for the alcohol and tobacco use in our study as it is self-reported 
usage which may be under- or falsely reported.  
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CHAPTER SIX  
CONCLUSION 
This study, to our knowledge, is the first of its kind in South Africa and provided valuable information 
to the forensic pathology environment. Our aim was to profile EV and B19 in SUDI cases to 
determine whether myocardial infections, known to be caused by these viruses, may be related to 
SUDI and can be implicated in the final COD. 
We observed that both EV and B19 do in fact circulate in our infant population. We also observed 
that features of inflammation and/or myocytolysis were found in a small number of cases, which 
almost all were PCR positive for one of both viruses investigated.  
Additionally, this study provides evidence regarding the validity of histology in diagnosis of 
myocarditis. It highlights the idea that it should be used in conjunction with molecular-based 
diagnostic tests when assigning COD in SUDI cases, specifically aiming to reduce the proportion of 
cases that remain unexplained or classified as SIDS. The results obtained from the study should be 
distributed to the forensic pathologists assigned to the SUDI cases to serve as supplementary tests 
and included in the case files when defining the final COD. 
The association between myocarditis and SIDS remains controversial. Although the literature that 
shows viruses associated with myocarditis are frequently detected in SUDI cases, and the prevalence 
of B19 and EV in our myocardial samples correlate with this, it does not seem as though myocardia l 
infections played a significant role in the final COD.  
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APPENDICES 
Appendix A: SB buffer composition 
20X SB buffer: 
• 8 g sodium hydroxide 
• 45 g Boric Acid 
Add milliQ water up to 1L. Mix well. 
  
Stellenbosch University  https://scholar.sun.ac.za
67 
Appendix B: Amplicillin composition 
100 mg/ml Ampicillin: 
• 1 g of sodium ampicillin 
Dissolve in sterile nuclease-free water to make a final volume of 10 ml 
Store at -20°C in 1 ml aliquots 
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Appendix C: Sample of SUDI questionnaire 
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Appendix D: Results for PCR assays 
PCR and histology results for the SUDI cases 
SUDI case B19 EV Histology 
001 + + - 
002 + + - 
003 + + - 
004 + - - 
005 + + - 
006 + + - 
007 + + - 
008 - + - 
009 + + - 
010 + - - 
011 + - - 
012 + - - 
013 + + - 
014 + - - 
015 + + + 
016 + + - 
017 + + - 
018 + + - 
020 + + - 
021 + + - 
022 + + - 
023 + + - 
024 + - - 
025 + - - 
026 + - - 
027 + - - 
028 + - - 
029 + - - 
030 + - - 
031 + + - 
032 + - + 
033 + + - 
034 + + - 
035 + + - 
036 + + - 
037 + - - 
038 + - - 
039 + + + 
040 + + + 
041 + + - 
Stellenbosch University  https://scholar.sun.ac.za
79 
042 + - - 
043 + + - 
044 + + - 
045 + + + 
046 + + - 
047 + + - 
048 + - - 
049 + + - 
050 + + + 
051 + - - 
052 + + - 
053 + - - 
054 + - - 
055 + - - 
056 + - - 
057 + - - 
058 + - - 
059 + - - 
060 + - - 
061 + - - 
062 + - - 
063 + - - 
064 - - - 
065 - - - 
066 + - - 
067 + - - 
068 + - - 
069 + - - 
070 + - - 
071 + - - 
072 + - - 
073 + + - 
074 + - - 
075 + + - 
076 + - - 
077 + - - 
078 + + - 
079 + - - 
080 + - - 
081 + + - 
082 + + - 
083 + + - 
084 + - - 
085 + - - 
086 + - - 
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087 + + - 
088 + - - 
089 + - - 
090 + - - 
091 + - - 
092 + - - 
093 + - - 
094 + - - 
095 + + - 
096 - - - 
097 + - - 
098 + - - 
099 + - - 
100 + - - 
101 + - - 
102 + - - 
103 + - - 
104 + - - 
105 + - - 
106 + - - 
107 + + - 
108 + - - 
109 + - - 
110 + - - 
111 + - - 
112 + - - 
113 + - - 
114 + + - 
115 + - - 
116 + - - 
117 + - - 
118 + - - 
119 + - - 
120 + - - 
121 - - - 
122 + - + 
123 - - + 
124 + - - 
125 + - - 
126 + - - 
127 + - + 
128 + - - 
129 + + - 
130 + - - 
131 + - - 
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132 + + - 
133 + + - 
134 + - - 
135 + - - 
136 + - - 
137 + - - 
138 + - - 
139 + - - 
140 + + - 
141 + - - 
142 + - - 
143 + - - 
144 + - + 
145 + - - 
146 + - - 
147 + - - 
148 + - - 
149 + - - 
150 + - - 
151 + - - 
152 + - - 
153 + - - 
154 + - - 
155 + - - 
156 + - - 
157 + - - 
158 + + - 
159 + - - 
160 + - - 
161 + - - 
163 + + - 
164 + - - 
165 + - - 
166 + - - 
167 + - - 
168 + - - 
169 - - - 
170 + + - 
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Appendix E: Gel extraction 
DNA extraction from agarose gel using NucleoSpin® Gel and PCR Clean-up kit () as below: 
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